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ABSTRACT 
Introduction: Leishmaniasis forced itself upon medical attention as an increasingly significant 
problem over the last decade hence it is associated with poverty in developing countries and 
considered as imported or re-emerging diseases in Europe. Leishmaniasis which is a globally 
widespread group of diseases is caused by obligatory, Intracellular pathogen of the immune system 
targeting macrophages and dendritic cells. In humans  the infection is transmitted through the bites 
of female sand flies. The symptoms ranging from disfiguring cutaneous and muco-cutaneous 
lesions that can cause widespread destruction of mucous membranes to fatal visceral disease 
affecting the haemopoetic organs. It is endemic in the tropical and subtropical regions of 88 
countries, sixteen are developed countries, 72 are developing countries, 13 of them are among the 
least developed. Sudan is one of the greatest foci worldwide where Leishmaniasis represents a 
serious health problem causing high number of fatalities. Leishmania donovani complex and 
L.major are known to be the etiologic agents, however, the Leishmania donovani complex parasites 
that causes different clinical forms, i.e. visceral (VL), cutaneous (CL), muco-cutaneous (ML) and 
post kala-azar dermal Leishmaniasis (PKDL) are genetically considered as a homogenous group. 
Objectives: To understand the correlation between the genetic diversity and the clinical 
manifestations. 
Specific Objectives 1) To genetically characterize isolates from Sudanese patients diagnosed with 
different types of leishmaniasis to understand the correlation between different clinical 
manifestations and the genetic profile of Leishmania.2) Investigate presence or absence of mixed 
infections and/ or hybrids. 3) To build up a reliable picture of the various phylogenetic subdivisions 
with relation to virulence, using the Internal Trascribed Spacer (ITS) gene, the Lyshmanolysin 
(GP63) and the cytochrome Oxidase sub- unit II gene. 
Materials and Methods: Comparative genome based approach was used to analyse the three genes, 
Cytochrome Oxidase II (COII) gene, the Internal Transcribed Spacer (ITS) and the GP63 (both 
gp63 3/4 and MSPC). 111 samples from 72 Sudanese patients suspected of different Leishmaniasis 
were used. Firstly a Real Time PCR was developed to pick up positive samples. Secondly, to detect 
the interspecific polymorphism at species level, Cytochrome Oxidase II (COII) gene was amplified 
for all Real Time PCR positive samples. The methodology encompasses the use of direct 
sequencing and cloning techniques. Thirdly, to detect the intraspecific polymorphism at strain level 
and the under types of some positive isolates, (ITS) and the GP63 (both gp63 3/4 and MSPC) genes 
were amplified , The methodology encompasses the use of cloning techniques. 
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Results and Discussion: 40 patients out of 72 (55.6%) and 58 samples out of 111 (52.3%)  were 
confirmed by the Real Time PCR as Leishmania positive. Five CL samples from five patients have 
been examined, three of them have been concomitantly infected with both L.donovani and L.major 
as confirmed by the cloned COII and ITS genes. The ITS sequence data analysis of L. major related 
colonies in the three CL samples revealed the presence of more than one strain /hybrid of L. major 
as different polymorphic sites were detected within and between patients. The other two CL 
samples were found to be caused merely by L.donovani, but different sequence patterns have been 
detected by the ITS gene. 
One patient possessed L. infantum similar COII sequence, the GP63 sequence data analysis of the 
same patient confirmed some colonies as L. infantum, while two out of the six identified 
polymorphic sites  in the ITS gene were similar to those characteristic for L.infantum different 
zymodemes. 
          The number of PKDL and ML samples was not sufficient to draw a conclusion., However, 
COII and ITS data pointed L.donovani as the causative agent. ITS data showed considerable 
different sequence patterns between colonies from the two samples. The same results were found 
regarding other samples attributed to VL. 
        Gp63 sequence data analysis of some colonies attributed to VL samples (namely 10 HBM, 
3HBM and 11HBM) has identified two genetic groups, both within the L. donovani complex but 
different from L. infantum and L. donovani .  
         Conclusions:  The study concludes that 1) affirmed the presence of mixed infection with L. 
donovani and L. major  from a single cutaneous aspirate in CL patients. To the best of our 
knowledge this is the first report of L. donovani and L. major mixed-infection in Sudan. 
Additionally no other cases of such mixed-infection from the same cutaneous sample were reported 
elsewhere. 2) the study assessed the circulation of more than one strain/hybrid of L. major and L. 
donovani between Sudanese patients. 3) the presence of L. infantum as an etiological agent of VL in 
Sudan has been affirmed by CO II and ITS genes. 4)  Leishmania isolates with mixed species or 
strains might be subjected to selective pressure upon parasite culture, so direct extraction from 
biological materials is important for characterization. 
These findings have important implications regarding the diagnosis, the choice of the most 
appropriate therapy and the possibility of developing drug resistance and at the same time set the 
stage for future studies as the prevalence of different species and vectors and the competence of 
Phlebotomus spp. in transmitting different Leishmania. 
 
 
V 
 
ABSTRACT 
Introduzione: Negli ultimi anni Leishmaniosi si imposta all'attenzione medica come un problema 
sempre più rilevante. Le malattie sono associate con la povertà nei paesi in via di sviluppo e 
considerate  importati o riemergenti in Europa. Leishmaniosi è un gruppo  di malattie globalmente 
diffusa causata da un patogeno intracellulare del sistema immunitario targeting i macrofagi e le 
cellule dendritiche. Nell'uomo l'infezione si trasmette attraverso le punture dei flebotomi. I sintomi 
variano dalle lesioni cutanea e muco-cutanea che possono causare vasta distruzione delle membrane 
mucose alle malattie mortale viscerale che colpisce gli organi haemopoetici. leishmaniosi è 
endemica nelle regioni tropicali e subtropicali di 88 paesi, sedici sono paesi sviluppati, 72 sono in 
via di sviluppo, 13 di loro sono tra i meno sviluppati. 
Il Sudan è conosciuto fra i più grandi focolai a livello mondiale dove Leishmaniosi rappresenta un 
grave problema di salute causando elevato numero di vittime. Leishmania donovani complex e 
Leishmania major sono noti per essere gli agenti eziologici, tuttavia, i parassiti della Leishmania 
donovani comlex che causano diverse forme cliniche, i.e viscerale (VL), cutanee (CL), muco-
cutanea (ML) e  post kala-azar Leishmaniosi (PKDL) sono considerati geneticamente un gruppo 
omogeneo.   
Obiettivi: Per comprendere la correlazione tra la diversità genetica e le manifestazioni cliniche.  
Obiettivi specifici: 1) geneticamente caratterizzare isolati da pazienti Sudanesi diagnosati di diversi 
tipi di leishmaniosi per capire la correlazione tra diverse manifestazioni cliniche e il profilo genetico 
di Leishmania.2) Indagare sulla presenza o assenza di infezioni miste e / o ibridi. 3) Per costruire un 
quadro attendibile delle varie suddivisioni filogenetici in relazione alla virulenza, utilizzando i gene 
Internal Transcribed Spacer (ITS) Lyshmanolysin (GP63) e il citocromo ossidasi II 
Materiali e metodi: è stato utilizzato un’approccio basato sul genoma comparativo per analizzare i 
tre geni, citocromo ossidasi II (COII), Internal Transcribed Spacer (ITS) e il GP63 (sia gp63 3/4 che 
il MSPC). Sono stati utilizzati 111 campioni provenienti da 72 pazienti sudanese sospettati di 
diversi Leishmaniosi.In primo luogo, un real time PCR è stato sviluppato per raccogliere campioni 
positivi. In secondo luogo, per rilevare il polimorfismo interspecifico al livello di specie, citocromo 
ossidasi II (COII) gene è stato amplficato per tutti i campioni positivi nel real time PCR. Il metodo 
comprende l'uso di sequenziamento diretto e tecniche di clonazione. In terzo ed ultimo luogo, per 
rilevare il polimorfismo intraspecifico al livello del ceppo e dei sotto tipi di alcuni isolati positivi, 
(ITS) e il GP63 (entrambi gp63 3/4 e MSPC) geni sono stati amplificati. Il metodo comprende l'uso 
di tecniche di clonazione 
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Risultati e Discussione: 40 pazienti su 72 (55,6%) e 58 campioni su 111 (52,3%) sono state 
confermate dal Real Time PCR come Leishmania positivi. Cinque campioni cutanei provenienti da 
cinque pazienti sono stati esaminati, tre di loro sono stati infettati in concomitanza sia con 
L.donovani che con L.major come è confermato dal clonaggio del COII e ITS geni. 
L’ analisi dei dati ITS delle colonie correlate a L. major nel tre campioni cutanee ha rivelato 
la presenza di più di un ceppo / ibrido di L.major come è stato dimostrato dai siti polimorfici rilevati 
all'interno dei pazienti e tra di loro. Gli altri due campioni cutanei sono stati causati soltanto da 
L.donovani, ma differenti tipi di sequenza sono stati rilevati dal ITS gene. 
Un paziente possedeva sequenza simile di L. infantum COII, il GP63 analisi di sequenza 
dallo stesso paziente ha confermato alcune colonie come L. infantum, mentre, due dei sei siti 
polimorfici individuati nel ITS gene erano simili a quelli caratteristici per L.infantum diversi 
zymodemi. 
Il numero di campioni PKDL e ML non era sufficiente per trarre una conclusione. Tuttavia, 
COII e ITS dati hanno indicato L.donovani come l’agente causale, ITS dati ha mostrato notevoli tipi 
di diversi sequenze tra le colonie dei due campioni. Gli stessi risultati sono stati trovati per quanto 
riguarda altri campioni attribuiti al VL. 
Gp63 analisi dei dati di sequenza di alcune colonie attribuite ai campioni VL (ossia 10 
HBM, 3HBM e 11HBM) ha individuato due gruppi genetici all'interno della L. donovani complex, 
ma diversi da L. infantum e L. donovani. 
Conclusioni: Lo studio conclude che 1) ha affermato la presenza di infezione mista con L. 
donovani e L. major da un unico aspirato cutaneo. a nostra conoscenza questo è il primo rapporto di 
L. donovani e L. maggiore mista-infezione in Sudan. In aggiunta altri casi di tale infezione mista 
dallo stesso campione cutanea non sono stati riportati altrove. 2) lo studio ha valutato la 
circolazione di più di un ceppo / ibrido di L. major e L. donovani tra pazienti sudanesi. 3) la 
presenza di L. infantum come agente eziologico di VL in Sudan è stato affermato da CO II e  ITS 
geni. 4) Leishmania isolati con le specie o ceppi misti potrebbero essere sottoposti a pressione 
selettiva durante la cultura, l’estrazione diretta da materiali biologici è importante per la 
caratterizzazione. 
Questi risultati hanno implicazioni importanti per quanto riguarda la diagnosi, la scelta della 
terapia più appropriata e la possibilità di sviluppare resistenza ai farmaci e allo stesso tempo, porre 
le basi per futuri studi come la prevalenza delle diverse specie e vettori e la competenza del 
Phlebotomus spp. nel trasmettere diversi Leishmania. 
  
VII 
 
LIST OF ABBREVIATIONS AND ACRONYMS 
 
Abbreviation Significance 
AIDS Acquired Immuno Deficiency Syndrome 
CL Cutaneous Leishmaniasis 
DALY Disability- Adjusted Life-years 
DCL Diffused Cutaneous Leishmanias 
FCS Fetal Calf Serum 
HAART Highly Active Antiretroviral Therapy 
HEPES hydroxyl-ethyl piperazine-ethane sulfonic acid 
HIV Human immunodeficiency virus 
IFN Interferon 
IL Interleukin 
LmjF L.major strain Friedlin 
LPG Lipophosphoglycan 
MCL Muco-Cutaneous Leishmaniasis 
MCL Marcov Cluster algorithm 
NO Nitric Oxide 
PBS Phosphate Buffer Saline 
PCR Polymerase chain Reaction 
SDS Sodium Dodecyl Sulfate 
SML Sudanese Mucosal Leishmaniasis 
SSG Sodium Stibogluconate 
TAMRA tetra-methyl carboxyrhodamine 
TEMED N,N,N′,N′-Tetramethylethylenediamine 
Th T helper cells 
TNF Tumor Necrosis Factor 
WHO World Health Organization 
ZCL Zoonotic  Cutaneous Leishmaniasis 
ZVL Zoonotic Visceral Leishmaniasis 
 
 
  
VIII 
 
LIST OF FIGURES 
 
Figure 1: Taxonomy of Leishmania (WHO, 2010). 
Figure 2: The Life Cycle of the Leishmania Parasite. 
Figure 3: Cutaneous Leishmaniasis patients. 
Figure 4: Muco-cutaneous Leishmaniasis patients. 
Figure 5: Visceral leishmaniasis  Patients. 
Figure 6: PKDL patients. 
Figure 7: The study area. 
 Figure 8: The DNA segments of the selected minicircle kDNA class used for amplification.  
Figure 9: The two DNA segments of the GP63 gene selected for amplification. 
Figure 10: four amplificates obtained by the primers AJS3/R1 and F2/DBY. 
Figure 11:  schematic demonstration of kDNA sequences obtained by direct sequencing of                 
four CL isolates showing nucleotide’s. 
Figure 12: schematic demonstration of kDNA sequences obtained by direct sequencing of ten                   
HBM  isolates and L.infantum reference. 
Figure 13: showing thirteen amplificates obtained by the primers COII F and COII R. 
Figure 14:  Phylogenetic tree of COII sequences. 
Figure 15 : Genetic differences of nine COII sequences. 
Figure 16: schematic demonstration of COII sequence obtained by direct sequencing of one CL                      
isolate. 
Figure 17: Phylogenetic tree of COII cloning  sequences. 
Figure 18: Genetic differences of   three COII cloned  sequences. 
Figure 19: ITS amplificates obtained by the primers LITSR and LITSRR. 
Figure 20: ITS sequence types found for strains of L.donovani complex (Kuhls et al 2005). 
Figure 21: 3HBM ITS polymorphic . 
Figure 22: 14 HBM ITS polymorphic sites. 
Figure 23: 17 HBM polymorphic sites. 
Figure 24: 105 PKDL polymorphic sites. 
Figure 25: 106ML polymorphic sites. 
Figure 26: 106 ML: the three different patterns of nucleotides. 
Figure 27:106 ML, poly CT, position 816 of the 850 nucleotide: the three different patterns of  
nucleotides. 
IX 
 
Figure 28: 107CL polymorphic sites. 
Figure 29:107 CL polymorphic sites at position 15, 60, 122, 153 and 768 . 
Figure 30:  111 CL polymorphic sites. 
Figure 31: partial segment of  two sequence patterns optained from the cloning of 108 CL sample 
Figure 32: 108 CL polymorphic sites. 
Figure 33: 109 CL polymorphic sites. 
Figure 34:  the structure of a hybrid sequence obtained from cloning of sample 109.  
Figure 35: The hybrid strain of the sample 109 compared to the L.donovani and L.major sequence  
patterns obtained from different clonies of sample 109. 
Figure 36: 110 CL polymorphic sites.  
Figure 37:  Phylogenetic tree of ITS cloning  sequence of cutaneous samples. 
Figure 38:  some amplificates obtained by the primers gp63 1/2 primers gp63 ¾. 
Figure 39: schematic demonstration of gp63 3/4 sequences obtained by direct sequencing of   
some VL isolates  showing   nucleotide’s overlapping. 
Figure 40: Phylogenetic analysis of the  sequences obtained from cloning of five samples   
from fiveVL patients  and the gp63
 SHORT
 (Mauricio et al 2007) reference sequences. 
Figure 41: Phylogenetic analysis of the sequences obtained from cloning of sample 14 HBM and 
the gp63
 EXT 
published sequences (Mauricio et al 2007). 
Figure 42: Phylogenetic analysis of the sequences obtained from cloning of sample 11 HBM and 
the gp63
 EXT 
published sequences (Mauricio et al 2007). 
 
 
 
  
X 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
LIST OF TABLES 
Table 1: Proven and suspected sand-fly vector species. 
Table 2: Summary of the L. major, L. infantum and L. braziliensis genomes (Peacock et al., 2007). 
Table 3: Provenance, numbers and types of samples collected included in the study 
Table 4: sequences of primers used for detection and characterization of Leishmania 
Table 5: Types and number of colonies obtained from each ITS cloned sample 
Table 6: the between groups mean distance of the ten representative sequences of clade 1, 14HBM 
sequences and L.donovani 
Table 7: number of the sequence patterns obtained from each patient compared to the gp63
SHORT
 
sequences Mauricio et al, 2007. 
Table 8: gp63 between groups mean distance 
XI 
 
LIST OF MAPS 
 
Map 1: The Distribution of Old and New World Cutaneous Leishmaniasis (WHO 2003, Public 
Health Mapping Group. Communicable Diseases (CDS)) 
Map 2: Distribution of Old and New World Visceral Leishmaniasis(WHO 2003, Public Health 
Mapping Group. Communicable Diseases (CDS). 
Map 3: Global distribution of leishmaniasis and leishmania/HIV co-infection (Report of the 
Scientific Working Group on Leishmaniasis WHO, 2004). 
Map 4: Approximate distribution in Europe of Visceral Leishmaniasis and its vector(WHO Report 
of the Scientific Working Group on Leishmaniasis 2004). 
Map 5: Approximate distribution in Europe of Cutaneous Leishmaniasis and its vector (WHO 
Report of the Scientific Working Group on Leishmaniasis 2004). 
Map 6: Distribution of visceral and cutaneous leishmaniasis in Sudan and South Sudan (Zijlstra and 
el-Hassan, 2001) 
Map 7: Distribution of CL due to L.major in Sudan: (el-Hassan and Zijlstra, 2001) 
Map 8: Distribution of known cases of mucosal leishmaniasis in Sudan (el-Hassan et al., 1995). 
Map 9: Sand Flies in Sudan and South Sudan (el-Hassan and Zijlstra, 2001). 
 
 
 
 
 
 
 
 
 
 
TABLE OF CONTENTS
DEDICATION I
ACKNOWLEDGEMENT II
ABSTRACT III
ABSTRACT V
LIST OF ABBREVIATIONS AND ACRONYMS VII
LIST OF FIGURES  VII
LIST OF TABLES X
LIST OF MAPS XI
CHAPTER ONE: PART ONE INTRODUCTION
INTRODUCTION 1
1.1  Leishmania Epidemiology 1
1.2  Diagnosis of Leishmania Infections 3
1.3  Leishmania Taxonomy 4
1.4  Leishmania Biology 5
The life cycle 5
1.5  Leishmania Species and Clinical Manifestations 7
Subclinical Infection 7
Cutaneous Leishmaniasis 7
Mucocutaneous Leishmaniasis 9
Visceral Leishmaniasis 10
Post Kalazar Dermal Leishmaniasis 10
Leishmania-HIV/AIDS Co-infection 11
1.6  Treatment 12
1.7  Vectors of Leishmania 13
Vector Taxonomy 13
Vector Distribution 14
Vector Biology 15
Species-restricted Vector competence 16
1.8 The Reservoir 18
Humans as Reservoir Hosts 18
Reservoir of Zoonotic Cutaneous and Mucocutaneous Leishmaniasis 18
Reservoir of Zoonotic Visceral Leishmaniasis 19
1.9  Immunopathology of Leishmania 19
1.9.1 Immune Response of Leishmaniasis Patients 20
1.9.2  Factors Involved in Pathogenicity and Virulence 20
Parasite factors 20
Host Factors 21
Host genetic variation and susceptibility to Leishmania infection: 21
Vector Factors 22
PART TWO
Molecular Genetic approach in Leishmania 24
2.1  Leishmania Genome 24
2.2  Gene Organization and Genome Content 24
2.3  Genes and Leishmania Parasite Tropism and Virulence 25
Gene Families 26
RNA Genes 26
Repetitive Sequences 26
Species- Specific Differences 26
PART THREE
Leishmaniasis in Sudan 31
 Sand Flies in Sudan and South Sudan 32
The Leishmania Reservoir in Sudan 32
Control, Diagnosis and Treatment of Leishmaniasis in Sudan 33
Rationale of the Study 34
Hypotheses 35
Objectives of the Study 35
General Objectives 35
Specific Objectives
Materials and Methods 36
2.1  Ethical Consideration 36
2.1  Study area 36
2.2  Samples Collection 37
VL Biological Samples 37
CL Samples 37
Extracted DNA 38
Leishmania Reference strain 38
2.3 Molecular Assay 39
Parasite Isolation and Culture Condition 39
2.3.2 DNA Extraction 39
DNA extraction from culture 39
DNA Extraction From Clinical Samples Spotted on Filter Papers 40
2.3.3  Real Time PCR  Assay 41
2.3.4  Polymerase Chain Reaction (PCR) 41
kDNA PCR 41
Cytochrome Oxidase II gene PCR 42
Internal transcribed Spacer (ITS) PCR 42
GP63 PCR 43
MSPC PCR 44
2.3.5  PCR Product Analysis 45
Acrylamide Gel Electrophoresis 45
Acrylamide Gel Staining and visualization 45
Sequencing Techinques and Sequence Analysis 45
2.3.6 Molecular Cloning Assay 46
RESULTS 49
3.1  Parasite Culture Results 49
3.2  Real Time PCR Results 49
3.3  kDNA Results 49
kDNA PCR Results 49
kDNA Sequences Results 49
3.4 Cytochrome Oxidase II gene Results 51
COII PCR Results 51
COII Direct Sequence Analysis Results 52
COII Cloning Results 54
3.5  Internal transcribed Spacer (ITS) Results 55
PCR Results 55
ITS Cloning Results 55
3.6 GP63 Results 69
PCR Results 70
GP63 cloning Results 71
3.7 MSPC Results 74
DISCUSSIO 76
CONCLUSION 81
REFERENCES 82
 
 
 
 
 
 
 
CHAPTER ONE 
 
 
INTRODUCTION 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 
  
INTRODUCTION 
 
1.1  Leishmania Epidemiology  
The Leishmaniases are a globally widespread group of diseases caused by obligatory, 
intracellular haemoflagellate protozoan parasites of the genus Leishmania (family 
Trypanosomatidae). The disease is transmitted generally by at least 30 species of sand flies 
(either Phlebotomus or Lutzomyia genera) and rarely by congenital and parenteral routes 
(Magill, 1995; Herwaldt, 2001). The protozoan was first discovered by William Leishman in 
1901 in India, and confirmed in 1903 by Charles Donovan. 
The disease is endemic  in the tropical and subtropical regions of 88 countries, 
including 16 developed countries and 72 developing countries, 13 of them among the least 
developed but its public health impact remains neglected (Desjeux, 2004). Population 
displacements and increasing cases of Leishmania/HIV co-infection brought new dramatic 
concerns to the disease (Alvar et al., 2008). Leishmaniasis affected individuals are estimated to 
be around 12-13 millions worldwide. Annually, 0.7-1.3 millions new cases of cutaneous 
leishmaniasis (CL) occur, about 95% of CL cases occur in the Americas, the Mediterranean basin, 
and the Middle East and Central Asia. Over two-third of CL new cases occur in six countries: 
Afghanistan, Algeria, Brazil, Colombia, Iran and Syria. 
        Regarding Visceral Leishmaniasis (VL), there are 200,000-400,000 new cases occurring 
annually, 90% of these cases are reported from six countries: Bangladesh, Brazil, Ethiopia, 
India, South Sudan and Sudan (WHO, 2014) and about 90% of Mucocutaneous Leishmaniasis 
(ML) form is reported in Bolivia, Brazil, Ethiopia and Peru (WHO, 2014). However, the real 
burden of leishmaniasis is greatly underestimated because substantial number of cases remains 
unrecorded and misdiagnosed (Guerin et al., 2002; Murray et al., 2005). The burden of 
leishmaniasis expressed in disability-adjusted life years (DALYs) is estimated to be from 
946,000 to 2,357,000 for males and 1,410,000 for females (Desjeux, 2004). 
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Map 1: The Distribution of Old and New World Cutaneous Leishmaniasis 
 
 
 
WHO 2003, Public Health Mapping Group. Communicable Diseases (CDS) 
 
 
Map 2: Distribution of Old and New World Visceral Leishmaniasis 
  
 
WHO 2003, Public Health Mapping Group. Communicable Diseases (CDS) 
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1.2  Diagnosis of Leishmania Infections 
Correct clinical diagnosis is vital before starting treatment for prompt initiation of proper 
therapy and to shorten the treatment schedule. Diagnosis of leishmania infections is based on: 
1.Direct demonstration of the parasite on stained smears (mainly Giemsa or Leishmania stain) 
has been considered as gold standard for diagnosis. Smears can be made from lymphoid 
aspiration, bone marrow aspirate, splenic aspirate (Siddig et al., 1988; Zijlstra et al., 1992), 
blood (Martinez et al., 1993) cutaneous skin aspirates and skin biopsies (Ghosh et al., 1995). 
2.Culture-based diagnosis is also a tool for parasite demonstration (Lightner et al., 1983; Sinha et 
al., 1993). Micro-culture method (MCM) which utilized micro capillary has also been 
introduced for diagnosis of CL (Allahverdiyev et al., 2004). 
3.Immunodiagnosis 
(i) Detection of parasite antigen in tissue, blood, or urine samples such as latex agglutination test 
(KATEX) (De Colmenares et al., 1995; Attar et al., 2001) 
(ii) Detection of non-specific or specific anti-leishmanial antibodies (immunoglobulin) (Vinayak   
et al., 1994; De Colmenares et al., 1995). Other Conventional methods for antibody detection 
included Gel Diffusion, Complement Fixation, Indirect Hemagglutination Test, IFA , and 
Countercurrent Immunoelectrophoresis Test (Haldar et al., 1981; Hockmeyer et al., 1984; 
Sinha and Sehgal, 1994; Sundar and Rai, 2002). Serodiagnostic method such as (ELISA) is 
also widely used (Bray et al., 1973; Sundar and Rai, 2002). Other widely used methods under 
field condition include the Direct Agglutination Test (DAT) (el Harith et al., 1988) and the 
user-friendly Immune-Chromatographic (ICT) rk39 strip test which is used in antibodies 
detection against VL (rk39 antibodies are absent in CL and ML). rk39 strip test has shown to 
be less reliable in East Africa compared to the Indian subcontinent (Ritmeijer et al., 2006; 
Srivastava et al., 2011). However, newly developed assay based on the detection of the k28 
fusion protein has been evaluated in studies performed in Sudan and Bangladesh. This method 
could be implemented as a first-line point-of-care test after its confirmation in large-scale 
field evaluations (Pattabhi et al., 2010). No data has been gathered and made available 
thereafter.  
 
 
 
 
 
 
4 
 
4.Cellular Immunity Test 
(i) Intradermal skin test: it measures delayed type hypersensitivity   in reaction to intradermal 
injection of Leishmania antigen. It relies on the strong T-cell responses usually accompanying 
CL, ML or cured VL (Haldar et al., 1983; Sundar and Rai, 2002). 
(ii) Lymphocyte proliferation test: in this assay, patient’s peripheral blood lymphocytes are 
cultured in presence of Leishmania antigen for five days, proliferation can be recorded either 
by the diagnosis of radioactive thymidine incorporation into the DNA of dividing cells, or by 
the measurement of the cytokine levels produced by the proliferating lymphocytes and 
comparisons with cytokines level from cultures where no antigen is added. This test is used in 
patients with ML, CL, sub-clinical or cured VL (Reed et al., 1990). The application of this 
assay in routine diagnosis is limited. 
5.Nucleic acid based detection: PCR amplification of parasite DNA and Real-time PCR 
techniques are widely used for diagnosis and species identification (Andresen et al., 1997; 
Osman et al., 1997; Lachaud et al., 2001). 
 1.3  Leishmania Taxonomy 
Classification of Leishmania organism was initially based on ecobiological criteria such 
as geographical and epidemiological distribution, vector, tropism and clinical manefestations 
(Bray, 1974; Lainson et al., 1987) and later on biochemical data (Arnot DE and Barker DC., 
1981; Miles et al., 1981) and immunological data (de Ibarra et al., 1982; Wirth and Pratt, 
1982). Presently, classification is based on the isoenzyme characterization (Rioux et al., 1990). 
However, the isoenzyme classification has been questioned after the wide Leishmania genetic 
evolution. Revision of the taxonomic status of Leishmania species has been proposed by 
different researchers (Schonian et al., 2010; Van der Auwera et al., 2011). 
The genus Leishmania belongs to the family Trypanosomatidae, order Kinetplastida, 
class Zoomastigophora, Subphylum Mastigophora, Phylum Sarcomastigophora, Subkingdom 
Protozoa, Kingdom Protista. Depending on the site of parasite development within the female 
sandfly vector,  the genus Leishmania is divided into two sub genera, Leishmania (Leishmania) 
and Leishmania (vianna) (Lainson et al., 1987). The two subgenera are divided into complexes 
and species as shown in Figure 1 
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1.4  Leishmania Biology 
Leishmania parasite has a digenic life cycle that alternates between intracellular a 
mastigote in a vertebrate host  and extracellular promastigote in the vector sandfly host. 
The life cycle  
When an infective sand fly feeds in a vertebrate host, metacyclic promastigotes enter the 
vertebrate host via the insect’s proboscis. The promastigotes are then phagocytosed by host 
macrophages where they metamorphose into amastigote forms after they exposed to the acidic pH 
of the phagolysosomes (Chang and Dwyer, 1976; Berman et al., 1979); they then reproduce by 
binary fission and increase in number until the cell eventually bursts and then infects other 
phagocytic cell (Figure 2).  
When female sand fly takes a blood meal from an infected vertebrate host, the ingested blood 
that contains amastigotes passes through the food canal to the midgut. Parasites of the subgenus 
Vianna establish an initial infection in the hindgut, where those of the subgenus Leishmania 
develop in the midgut (Lainson, 1984). 
Figure 2: The Life Cycle of the Leishmania Parasite 
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Source: Centre of Disease Control and prevention (CDC) 
 
Sand fly midgut cells secrete peritrophic matrix (PM) that completely envelops the fresh blood 
meal in  protein and glycoprotein sac and at the same time protect the midgut epithelial cells from  
damages by blood contents (Sacks, 1997). 
In the sand fly midgut, two developmental stages of promastigotes were recognized, the 
procyclic and the metacyclic stages (Sacks and Perkins, 1985). The procyclic attachs to the 
epithelial cells of the midgut via binding to the lipophosphoglycan (LPG) (Sacks and Kamhawi, 
2001). Metacyclic parasites undergo changes in the LPG structure reducing the ability of binding to 
midgut and allow the release of the parasite and its migration to the salivary glands of the vector 
and thus the sand fly becomes competent to transmit the infection (Sacks et al., 2000). 
 
1.5  Leishmania Species and Clinical Manifestations 
In Human, both children and adults, leishmaniasis disease is caused by nearly two-dozen 
distinct Leishmania species. It manifests itself in several diverse clinical forms including ulcerative 
skin lesions, destructive mucosal inflammation, and disseminated visceral infection (Kala azar) 
(Herwaldt, 1999; Desjeux, 2001; Desjeux, 2004). Diseases outcome are similarly diverse. Variable 
disease expressions have also been shown in naturally infected animals (Lainson et al., 2002) and, 
especially, experimentally infected ones (Alvar et al., 2004; Murray et al., 2005). Disease 
expression and manifestations vary depending on parasite species, endemic region, host factors and 
host responses (Weigle and Saravia, 1996; Murray et al., 2005). 
 
Subclinical Infection 
Viscerotropic Leishmania species can cause asymptomatic infection (Badaro et al., 1986; 
Follador et al., 2002; Gama et al., 2004; Riera et al., 2004). Diverse predisposing factors have been 
reported and attributed to the sub-clinical infection such as host immunogenetic polymorphisms 
(Davies and Mazloumi Gavgani, 1999; Blackwell et al., 2004) and the host nutritional status (Cerf 
et al., 1987). 
 
Cutaneous Leishmaniasis 
The causative organisms of CL are L. tropica, L. major, L. aethiopica, L. donovani and 
L. infantum in the Old World. In the New World CL is caused by multiple species of both the 
Leishmania subgenera [L.(Leishmania): L. amazonensis, L. infantum, L. mexicana, L. 
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venezuelensis] and the Viannia subgenera [L.(Viannia): L. braziliensis, L. guyanensis, L. 
panamensis, L. peruviana] (Monge-Maillo and Lopez-Velez, 2013a). CL is frequently self-
healing unless secondary bacterial infection develops. Usually, it affects exposed parts of the 
body with incubation period that varies from 1 week to several months depending  mainly on 
the Leishmania species involved and the size of the inoculum. (Grevelink and Lerner, 1996; 
Salman et al., 1999). The fully mature lesion remains stable for several weeks before healing 
starts (Kubba et al., 1987).   Differential diagnosis should be made to exclude other diseases. 
Diffused Cutaneous Leishmaniasis (DCL) is another form of the CL which is caused 
either by L. aethiopica or L. amazonensis (Salman et al., 1999). It is characterized by lack of 
Leishmania-specific cellular immune response and thus limited inflammatory reaction (Bañuls 
et al., 2007). DCL usually starts with a primary lesion that progresses to numerous ulcerated 
nodules and plaques that disseminate to other skin area (Salman et al., 1999). Infections 
persisting for more than 1–2 years are regarded as chronic CL (Dowlati., 1996). 
 
 
 
  
 
 
 
 
 
 
Affected patients have a vigorous cellular immune   response but low antibody titer (Salman et al., 
1999). 
 
 
 
 
 
 
 
 
 
 
 
 
 
              Figure 3: CL patients 
Leishmania Recidiva Cutis is a rare form associated with 
L. tropica in the Old World and L. braziliensis in the New 
World. This form of the disease refers to the development 
of new lesions within the scar of a healed acute lesion 
(Salman et al., 1999), incubation period ranges 1–15 
years and in some cases different Leishmania strains from 
the primary eziology were found suggesting either change 
in the immune status of the host or an exogenous 
reinfection (Saravia et al., 1990).  
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Mucocutaneous Leishmaniasis  
MCL involves the mucous membranes of the upper respiratory tract. It occurs when 
cutaneous lesions expand to the mucosal region or through metastasis. It is not self-healing and if 
left untreated it develops to mutilation or tissue destruction (Reithinger et al., 2007; Strazzulla et 
al., 2013). Treatment failure and relapses are common 
 
  
 
 
 
 
                  
 
 
 
 
Unlike South American ML, Sudanese Mucosal 
Leishmaniasis (SML) is not preceded or accompanied by a cutaneous lesion (el-Hassan et al., 
1995). Few sporadic cases of SML have been reported in Sudan, most of which were from endemic 
areas of VL. Isoenzyme characterization identified that L. donovani zymodeme  MON 18 isolated 
from ML patients is the same that causes VL in the western Upper  Nile  Province and among the 
Misairriya  tribe in Kordofan (el-Hassan et al., 1994; el-Hassan et al., 1995) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                        Figure 4: ML patients 
 (Amato et al., 2008; David and Craft, 2009). MCL it is a 
typical Leishmaniasis disease in the  New World.  Ninety 
per cent of the cases occur in Brazil, Bolivia, ethiopia , and 
Peru (WHO., 2014) It is mostly related to Leishmania 
species of the New World such as L. braziliensis,L. 
panamensis and L. guyanensis (Guerra et al., 2011). 
Nonetheless, mucosal lesions have been reported in the Old 
World due to L. donovani (el-Hassan et al., 1994; el-
Hassan et al., 1995; Pulimood et al., 2012), to L. major 
(Alborzi et al., 2013) and to L. infantum in 
immunosuppressed patients (Ehlert et al., 2013).                        
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Visceral Leishmaniasis 
Also known in Asia as ' black fever' or 'kala-azar', VL is the most severe form of the disease. The  
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
Post Kalazar Dermal Leishmaniasis  
Post-kala-azar Dermal Leishmaniasis (PKDL) is a dermatosis that usually occurs in VL 
patients who have been successfully treated and rarely, in individuals who have no previous history 
of symptomatic VL (Gasim et al., 2000; Zijlstra et al., 2003). The disease is mainly caused by L. 
donovani in Indian sub continent and East Africa, however, few cases have been reported to be 
caused by L. infantum, L. chagasi, or L. tropica.(Sacks et al., 1995; Singh et al ., 2011). Disease 
pathogenesis is thought to be immunologically mediated (Singh et al., 2011). 
It has been estimated that after successful treatment of VL, about 10–20% cases in India and 50–
60% cases in Sudan develop PKDL (Ramesh and Mukherjee, 1995; Zijlstra and el-Hassan, 2001b). 
PKDL patients  are thought to act as human reservoir for the parasite (El Hassan and Khalil, 2001). 
Figure 5: VL patient 
parasite invades internal organs (spleen, liver and bone marrow) and the 
consequences are usually with an almost 100% mortality rate if left untreated 
(Desjeux, 2004). It is characterized by irregular fever, loss of weight, 
splenomegaly, hepatomegaly and/or lymphadenopathy and anaemia (Zijlstra 
and el-Hassan, 2001a). Among the 200,000 to 400,000 new cases of VL, which 
occur annually, 90% are concentrated in 6 countries, Bangladesh, Brazil, India, 
Ethiopia, South Sudan and Sudan (WHO., 2014). 
VL is caused by L. donovani in the Indian subcontinent and in East Africa, by L. 
infantum in the Mediterranean region and by L. chagasi, which is closely related 
or undistinguishable from L. infantum in the New World, mainly in Brazil, Peru 
and Paraguay (Berman, 1997; Herwaldt, 1999). However, L. tropica and L. 
major have been isolated from bone marrow cultures of patients with systemic 
leishmanial infection in Kenya, Iraq, the Middle East and India (Mebrahtu et al., 
1991; Al-Diwany et al., 1995; Magill, 1995). Occasionally, L. amazonensis in 
South America can produce VL (van Griensven and Diro, 2012). 
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Leishmania-HIV/AIDS Co-infection 
The first case of leishmaniasis associated with HIV infection was reported in 1985, and the 
numbers of cases have subsequently increased rapidly in Southern Europe. Thirty-five countries 
have since then reported cases of co-infection. After the introduction of the HAART (Highly Active 
Anti-Retroviral Treatment), the numbers of co-infected cases in European countries where the 
disease is endemic fell sharply. However, the problem has expanded to other major foci of 
leishmaniasis in the world due to the increased overlap of the two diseases (Tremblay et al., 1996; 
Alvar et al., 2008). 
Both Leishmania and HIV disease exert a synergistic detrimental effect on the cellular immune 
response because they target similar immune cells (Tremblay et al., 1996). HIV increases the risk of 
developing VL leishmaniasis by 100 to 2,320 times in areas of endemicity, reduces the likelihood of 
a therapeutic response and greatly increases the probability of relapse (Pintado et al., 2001; Alvar et 
al., 2008) and at the same time VL promotes the clinical progression of HIV disease and the 
development of the AIDS- defining conditions. In South Europe, France, Italy, Portugal and Spain 
were mainly involved in Leishmania HIV co-infection, while in South Asia the co-infection was 
found in Bangladesh, India and Nepal. Brazil is the epicentre of the HIV/AIDS epidemic in South 
America, and in sub Saharan Africa the disease is well reported in Burkina Faso, Ethiopia, Somalia, 
Sudan and Kenya. (Alvar et al., 2008). 
 
 
  
Figure 6: PKDL patients 
PKDL usually develops within months to several year (2–7 years) after 
apparent cure of kala-azar.  
Leishmania parasites were detected in lymph node and/or bone marrow 
aspirates of the PKDL cases. Clinically, the  PKDL is characterized by 
the appearance of macules, papules or nodules in the skin especially on 
the face but other parts of the body may also be infected (Zijlstra and el-
Hassan, 2001b). The disease may develop particularly severe and 
generalized skin lesions especially in children (el Hassan et al., 1992; 
Zijlstra et al., 2003).  
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Map 3: Global distribution of leishmaniasis and leishmania/HIV co-infection  
 
Report of the Scientific Working Group on Leishmaniasis WHO, 2004 
 
1.6  Treatment 
Cutaneous disease is usually self-healing (Murray et al., 2005), the treatment options are 
used to accelerate cure, reduce scarring especially at cosmetic sites and to prevent dissemination or 
relapse (Murray et al., 2005). Drug efficacy is based on the Leishmania species involved, the 
geographical regions and the clinical presentations. CL treatment can follow topical or systemic 
regime (Monge-Maillo and Lopez-Velez, 2013a). Local therapies offer less systemic toxicity, and 
include thermotherapy, cryotherapy, paromomycin ointment and local infiltration with antimonials, 
whilst systemic treatment with azole drugs, miltefosine, antimonials or amphotericin B formulations 
are reserved for complex cases (Monge-Maillo and Lopez-Velez, 2013a). Combinations of local 
therapies and parenteral pentavalent antimonials are also common and showed to have an additional 
therapeutic effect (Monge-Maillo and Lopez-Velez, 2013a). 
Mucosal diseases must be treated as it can produce potentially life threatening inflammatory 
disease.  Parenteral antimony is the drug of choice. Amphotericin B can be used as rescue therapy 
(Murray et al., 2005). 
PKDL disease is not routinely treated hence the majority of cases heal spontaneously within 
one year. Treatment is limited to patients with severe, disfiguring or long persisting lesions and to 
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young children with oral lesions that interfere with their feeding. Sodium stibogluconate (SSG) and 
liposomal amphotericin B are the drugs of choice (Murray et al., 2005). 
Visceral disease expression varies from sub-clinical to fatal systemic. Active VL may also 
represent relapse or late reactivation of subclinical or previously treated infection (Murray et al., 
2005). Factors as development of drug resistance, malnourishment, geographical location and 
concomitant infections should be considered upon choice of the proper treatment (Monge-Maillo 
and Lopez-Velez, 2013b). 
Since the late 1940s, the traditional treatment for VL has been the use of pentavalent 
antimonials. However, in the1980s, conventional amphotericin B deoxycholate was introduced, 
followed by lipid formulations of amphotericin B (liposomal amphotericin B) (Monge-Maillo and 
Lopez-Velez, 2013b), which is considered to be the drug of choice in high-income countries 
(Desjeux, 1996), the intramuscular Paromomycin and later, the oral miltefosine were developed as 
drug option for VL. In East Africa, the combination of sodium stibogluconate and  paromomycin is 
common (Murray et al., 2005). 
 
1.7  Vectors of Leishmania 
Phelobtomine sand flies are the only  known natural vector of  Leishmania (Ready, 2013), 
however, recently other haematophagous arthropods such as ticks (Rhipicephalus sanguineus) 
(Dantas-Torres et al., 2010; Dantas-Torres, 2011) and the day-feeding midges (Diptera: 
Ceratopogonidae) (Dougall et al., 2011) have been incriminated. Table 1 shows proven and 
suspected vectors of Leishmania. 
Vector Taxonomy 
There is no universal agreement on the generic and higher classification of sand-flies. 
Phlebotomus, Sergentomyia and Chinius are the three Old World genera recognized and widely 
accepted, however, others have been named but they are of unknown medical importance (WHO, 
2010). For Neotropical sand-flies, three genera, 15 subgenera and 11 species groups have been 
recognized for decades, but this classification has been strongly criticized because it failed in 
revealing the evolutionary relations between specie belonging to the genus Lutzomyia (WHO, 
2010). Several revisions have been proposed, but none has been universally accepted (WHO, 2010). 
A most recent and comprehensive taxonomy classifies the 464 species of Neotropical sand-flies into 
22 genera, 20 subgenera, 3 species groups and 28 series but yet it has not  been fully accepted and 
further changes are expected (WHO, 2010).  
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 The phelobtomine sand flies that are known as natural vector of Leishmania belong to the 
Family Psychodidae, Subfamily Phlebotominae of the genus Phlebotomus (Old World), and 
Lutzomyia (New World) (Killick-Kendrick, 1990). Sand-flies transmit many zoonotic diseases 
(Arboviruses, Bartonelloses and especially Leishmaniases) of importance to human health. Among 
over 800 species of sand-fly recorded, 98 are proven or suspected vectors of human Leishmaniases ( 
42 Phlebotomus species in the Old World and 56 Lutzomyia species in the New World) (Maroli et 
al., 2013). 
 
Vector Distribution 
Altitudinal distribution of sand-flies extends from below sea level to 3300 m above sea level in 
Afghanistan (Lane and Crosskey, 1993; Maroli et al., 2013). Usually they are limited to areas where 
daytime temperature is above 15.6 C° for at least three months of the year (Lane and Crosskey, 
1993) in Asia, Africa, Australia, Southern Europe and the Americas (Killick-Kendrick, 1999). 
Sand-fly population densities change in areas characterizes with seasonal fluctuations in 
temperature. They are absent from New Zealand and the Pacific islands (Lane and Crosskey, 1993). 
Population density reaches its peak towards the end of the rainy season in arid and semi-arid zones 
and reflow at the end of the dry season. Adults of some species disappear during the driest and / or 
coldest seasons (Sacks, 2001). Maps 4 and 5 demostrate the approximate distribution in Europe of 
VL and its vector compared to CL and its vector. 
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Map 4 and Map 5:  Approximate distribution in Europe of Visceral Leishmaniasis and its vector 
compared to Cutaneous leishmaniasis and its vector 
 
WHO Report of the Scientific Working Group on Leishmaniasis 2004 
Vector Biology 
The biology of each species of sand-fly is unique and complex and the preferences of 
vectors for different vertebrates vary according to species and to the availability of hosts (WHO, 
2010). The time from an infecting blood-meal until a female can transmit leishmaniasis by bite is 
probably 1–3 weeks, although the precise period is not known for any species of Leishmania and 
undoubtedly varies according to the gonotrophic cycles of the different vector species, the ambient 
temperature and, perhaps, the sugars taken by the females (WHO 2010). Phlebotomine sand-flies 
undergo four developmental stages: egg, larva, pupa, and adult (WHO, 2010). The immature stages 
need high relatively moist and warm habitats. The eggs are laid by adult females in sheltered habitat 
rich in organic content, such as animal excreta and soil. Eggs (0.3–0.5 mm in length) are initially 
white or light grey in colour but often turn dark brown or black within a few hours of oviposition 
(Maroli et al., 2013). Egg hatching is highly temperature-dependent while larval development is 
generally slow. First-instar larvae emerge in 12–19 days, pupae in 25–59 days, and adults in 35–69 
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days (Volf and Volfova, 2011). Both male and female require carbohydrate for energy, supplied by 
sugar secretions from plants and from honeydew (Killick-Kendrick and Killick-Kendrick, 1987; 
Molyneux et al., 1991). With the exception of few species, female phlebotomine sand-fly requires 
at least one blood meal in order to complete development of egg batches. Unlike mosquitoes, their 
attack on the host is silent. Adults are usually dormant during the day resting in cool humid sites 
that vary according to species such as animal burrows, bird nests, human dwellings and caves 
(Killick-Kendrick, 1999; Maroli et al., 2013). Adults are mainly active in the evening, at night and 
in the early morning, although they can bite during the day if disturbed. The flight range of adult 
sand-fly is very short (about 300 m) and thus adult activities are usually restricted to the vicinity of 
larval breeding sites. However, peridomestic species disperse at longer distances than forest one 
(WHO, 2010). The flight speed is less than that of mosquitoes and in the order of 1 m/s (WHO, 
2010) and they are unable to fly at wind speeds above this rate, which limits their distance of 
dispersal (WHO, 2010). 
 
Species-restricted Vector competence 
Species-restricted vector competence comes from laboratory based studies. Vectors can be 
divided into specific vectors, which support the growth of only one species of Leishmania, and 
permissive vectors, which support the growth of more than one species (WHO, 2010). 
Different factors determine the ability of a given sand-fly species to act as specific or permissive 
vectors, these factors include: 
(i)The ability of the Leishmania parasite species to resist the digestive action of the enzymes 
produced in the midgut of the fly. 
(ii)The lipophosphoglycan-binding sites on the inner surface of the fly gut should match the 
lipophosphoglycan on the surface of the promastigotes. 
(iii) Successful establishment, growth, differentiation, migration and transmission of the parasite to 
the vertebrate host. 
Despite its wide distribution, P. papatasis is known as specific vector of L. major in 
natural transmission, however, an experimental evidence of P. papatasi infection with hybrid 
strains of L. infantum / L. major causing visceral disease in HIV-positive patients (Volf et al., 
2007) has been documented.  Based on these results P. papatasi has been suggested as vector 
of this hybrid in nature (Volf et al., 2007) 
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Table 1: Proven and suspected sand-fly vector species (The Biology of Leishmania - Sandfly 
Interaction- book. Page 20)  
Leishmania species Proven or suspected vector 
sand fly species 
Place of known or suspected 
transmission 
 
 
 
L.donovani 
P. (E)argentipes India,Bangladesh, Nepal 
P.(P.).alexandri West China and north Africa 
P.(La.)orientalis Sudan and Ethiopia 
P.(S.)martini Kenya, Ethipoia 
P.(S.)celiae Kenya, Ethipoia 
 
 
L. infantum 
P.(La) perniciosus 
P.(La) ariasi 
P.(La)perfiliewi 
P P.(La)neglectus. 
 
Mediterranean 
alexandri Iran and Middle East 
P.(A.).brevis Iran 
 
L.major 
P.(Ph.)papatasi Norht Africa and middle East 
P.(Ph.)duboscqi Sahelian Africa 
L.tropica P.(La.)acleatus Kenya 
P.(La.)guggisbergi Kenya 
P.(P.)sergenti Asia, Middle East and north Africa 
L.aethiopica P.(La.)longipes Kenya, Ethipoia 
and  P.(La.)pedifer Kenya, Ethipoia 
NewWorld species 
 
L.braziliensis 
Lu.(Ps.)carrerrai Western Amazon Basin 
Lu.(Ps.)compexa Lu.(N.)intermedia 
Lu.(Ps.)wellcomei Lu.(N.)Whitmani 
 
Brazil 
Lu.ovallesi Venezuela, Guatemala 
L.chagasi Lu.(lu.)longipalpis Centeral America, Brazil, Venezuela 
L.colombiensis Lu.(H.) hartmanni Colombia 
 
L.guyanensis 
Lu.(N.) anduzei Northern, South America, Brazil 
Lu.(N.) umbratilis Amazon Basin, Brazil, French Guiana 
L.lainsoni Lu.(T.) ubiquitalis Brazil, Peru 
 
 
L.mexicana 
Lu.(D) anthophora 
Lu.(lu) diabolica 
Texas USA 
Lu.(H.) ayacchensis Ecuador, Peru 
Lu.(N) olmeca  
 
L.panamensis 
Lu.(V) ovallesi Panama, Venezuela 
Lu.(N.) trapidoi Central America, Colombia 
L.peruviana Lu.(H.) peruensis 
Lu.(V) verrucarum 
Peru 
L.venezuelensis Lu.(N) olmeca Northern South America 
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1.8 The Reservoir 
In zoonotic leishmaniasis the relationship between the parasite, the sand-fly, and the mammalian 
host(s) is complex and considered as a self-sustaining, independent system (Ashford, 1996).  
Ashford et al established three types of reservoir host:  
(i)The primary reservoir hosts which is responsible for the long-term maintenance of the 
infectious agents and are basically mammals. 
(ii) The incidental hosts which are irrelevant to the long-term persistence of the disease. 
(iii)Liaison hosts which bring the infectious agents to the vicinity of man and facilitate their 
transmission. 
Various species of animals may become infected with Leishmania parasites and develop lesions 
but their roles as reservoirs need to be determined. A reservoir host needs an intense–fly contact, 
long-relatively non-pathogenic course of infection and an identical genotype of the parasite as that 
in human (WHO, 2010). 
 
Humans as Reservoir Hosts 
The two Leishmania species that are thought normally to be transmitted between humans are 
L. donovani and L. tropica, both tend to occur in unstable epidemics and may depend on people 
displacements from endemic foci where most people are immune, to new foci (Ashford, 1996). 
PKDL infected individuals are thought to be source of infection (El Hassan and Khalil, 2001) , 
whilst HIV-coinfected patients are known to be highly infectious to sand flies, the role of 
asymptomatically infected individuals in the transmission cycle is currently unknown (WHO, 
2010). Humans have also thought to play a reservoir role in some outbreaks caused by L. 
braziliensis, L. guyanensis and L. panamensis (WHO, 2010). 
 
Reservoir of Zoonotic Cutaneous and Mucocutaneous Leishmaniasis 
Humans play minimal role in the transmission of ZCL caused by L. major (Schlein and 
Jacobson, 1996). In arid regions the main reservoir host of L. majoris is the great gerbil 
Rhombomysopimus spp. (Ashford, 1996; Yaghoobi-Ershadi and Javadian, 1996), while in Middle 
East and North Africa, the sand fat jird (Psammomysobesus), Merionesshawi, Merionessacramenti 
and Gerbilluspyramidum are the primary reservoirs (Ashford et al., 1977; Schlein et al., 1984; 
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Morsy et al., 1993; Saliba et al., 1994; Fichet-Calvet et al., 2003). Merioneslibycus, M. crassus 
,Mastomysnatalensis and Arvicanthusspp are suspected reservoir  rodents  for L. major (Saliba and 
Oumeish, 1999). Proechimysguyanensis and Proechimyscuvieri are primary reservoir hosts of L. 
amazonensi, while Oryzomys, Nectomys and Dasyprocta are secondary hosts. Many species of 
ground rodents are involved in the transmission cycle of L. mexicana (WHO, 2010). 
Two species of hyrax, Procaviacapensis and Heterohyraxbrucei, are the reservoir hosts of 
L. aethiopica in East Africa (WHO, 2010).  
Several species of sloth are important reservoir hosts of various Leishmania species in New 
World. Choloepusdidactylus is a major reservoir host of L. guyanensis in Brazil and  L. shawi in the 
Amazon region (WHO, 2010). While the Choloepushoffmani and Bradypusgriseus are primary 
reservoir host of L. panamensis. B. infuscatus has also been reported to be infected by L. 
panamensis, but its importance in the zoonotic cycle is not clear (WHO, 2010). The Lesser anteater 
(Tamanduatetradactyla) is the principal reservoir of L. guyanensis in Brazil. The Opossums 
(Didelphismarsupialis) is considered as a secondary reservoir host for L. guyanensis and L. 
brazielienses (Arias et al., 1981). 
Reservoir of Zoonotic Visceral Leishmaniasis 
The reservoir of L. donovani is mainly humans (El Hassan and Khalil, 2001; Zijlstra and el-
Hassan, 2001b). However, in Sudan other species are incriminated as the Arvicanthis niloticus (el-
Hassan et al., 1995). 
The reservoir of L. infantum/L. chagasi is usually the dog. Naturally infected asymptomatic 
dogs are believed to play an important role in the transmission cycle as they are easily infective to 
sand-flies under experimental conditions (WHO, 2010). However, wild Canidae such as fox 
(Vulpes spp.), jackal (Canisaureus), wolf (Canis lupus) and the raccoon dog (Nyctereutes 
procyonoides) have been found to be infected with L. infantum  in both  Old World and New World, 
but their role as reservoir has not been fully established (WHO, 2010). Domestic cat (Felis catus) 
may act as secondary reservoir for L .infantum /chagasi (Poli et al., 2002; Savani et al., 2004). 
1.9  Immunopathology of Leishmania 
In humans, different patterns of immunological response are observed according to the 
clinical manifestation and exposure to different Leishmania species. Nevertheless, how different 
Leishmania spp cause human diseases and why the clinical symptoms are so variable remain 
enigmatic (Bañuls et al., 2007). 
The majority of Leishmania species are adapted to a large range of hosts. In human and 
other less adapted animals Leishmania infections can produce a wide range of diversified 
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pathologies ranging from asymptomatic carriers to benign cutaneous lesions to more serious life 
threatening disease such as the visceral form. In well-adapted animals infections remain 
asymptomatic (Lainson et al., 1987). However, the rate of asymptomatic carriers is not accurately 
known, but it has been suggested that it is higher than expected (Sharma et al., 2000; Gama et al., 
2004; Riera et al., 2004). 
1.9.1 Immune Response of Leishmaniasis Patients 
In asymptomatic individuals, the natural immune response can eliminate or control the 
parasites. Macrophages are key cells in the host immune defense, they are the first host cells to 
contact and be parasitized by Leishmania (Basu and Ray, 2005). Together with dendritic cells, 
macrophages present the parasite antigens to T cell receptors via the major histocompatibility 
complex (MHC) molecules (Zinkernagel and Hengartner, 2001) forming acquired immune response 
which could be influenced by the cytokine context and the Leishmania peptides presented (Bañuls 
et al.,2007). 
During infection, Leishmania parasites resist the T cell mediated immune responses through 
complex and various strategies and mechanisms (Antoine et al., 2004 ). In humans, different 
patterns of immunological response are observed according to the clinical manifestation and 
exposure to different Leishmania species. As example: Th1 response is present in patients with self-
healing cutaneous lesions and absent in those with diffuse cutaneous Leishmaniasis (Kemp et al., 
1994; Ajdary et al., 2000), while in patients with Mucocutaneous Leishmaniasis a mixed Th1/Th2 
response with high interferon-γ (IFN-γ) levels were present (Carvalho et al., 1985; Bacellar et al., 
2002). In VL mixed Th1/Th2 response is observed with production of IFN-γ with interleukin-10 
(IL-10)(Ghalib et al., 1993) and in individuals with asymptomatic or subclinical infections of 
visceralizing species of Leishmania,  peripheral blood mono nuclear cell (PBMC) proliferation and 
production of IL-2, IFN-g and IL-12 were observed. 
In cured patients, both Th1 and Th2 clones producing IFN-γ and IL-4 have been isolated 
(Kemp et al., 1993). 
1.9.2  Factors Involved in Pathogenicity and Virulence 
Parasite factors 
Although Leishmania virulence may be modulated by the environmental and genetic factors 
of their mammalian hosts and sand fly vectors, molecular determinants of parasite remains the key 
elements hence there is no Leishmaniasis without intact living Leishmania parasite (Chang and 
McGwire, 2002). 
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Chang et al (2002) identified two different groups of parasite molecules that thought to be 
involved in leishmanial mechanisms of virulence, these are: 
(i)   Invasive/Evasive determinants: 
Infection-related parasite cell surface and secreted molecules allow to establish successful 
intracellular parasitism in phagolysosomes or parasitophorous vacuoles of macrophages (Chang and 
McGwire, 2002). They enhance evasion of humoral factors, attachment of parasites to macrophages 
followed by the intracellular entry into phagocytes, the intracellular survival of the endocytized 
parasites, differentiation of promastigotes to amastigote and amastigote replication (Chang and 
McGwire, 2002).They protect not only the parasite its self, but also the infected host cell from 
premature cytolysis. These determinants are crucial for infection but they produce no pathology of 
the host (Chang and McGwire, 2002). Invasive/evasive determinants include among others 
phosphoglycans (PG), lipophosphoglycans (LPG), glycosylphosphatidylinositol (GP1), 
proteophosphoglycan (PPG), Leishmanolysin (GP63) and cysteine protease (CPs)  (Chang and 
McGwire, 2002). 
(ii) Pathoantigens 
Are all molecules that  are capable of inducing host immunopathology as the principal cause of 
clinical symptoms, are conserved structural or soluble cytoplasmic proteins which are often 
complexed with other molecules to form sub-cellular particles (Chang and McGwire, 2002). They 
produce high antibodies titers and include among others Cytoskeleton (as kinesin and tubulins), 
ribosomes ( PO, P2a and b), nucleosomes (as H2A/B, H3 and H4) and glycosomes  such as TPI. 
The molecules listed have been found to contain immunogenic B-cell pitopes (Chang and McGwire, 
2002). 
 
Host Factors 
 Host genetic variation and susceptibility to Leishmania infection: 
Evidence from animal models and humans indicates that host factors play an important role 
in determining both disease severity and resolution (Cabello et al., 1995; Mohamed et al., 2003). 
Despite the differences between the human disease and the mouse models, much of the knowledge 
gained from studies in mice has found to be applicable to human Leishmaniasis 
(Sakthianandeswaren et al., 2009). Candidate genes identified in mice as important in host response 
to infection, showed to be useful in identifying genetic polymorphisms involved in the human 
response to Leishmaniasis (Sakthianandeswaren et al., 2009). Researches using candidate gene 
association analysis and genome-wide linkage studies in selected families from Sudan, Brazil and 
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India, identified number of genes/regions related not only to environmental risk factors but also to 
genes responsible for determining type 1vs type 2 cellular immune responses (Blackwell et al., 
2009). Moreover, VL development has been demonstrated to be associated with two loci on 
chromosomes 22q12 and 2q23-q24  among Aringa ethnic group in Sudan (Bucheton et al., 2003), 
also  IL-2 receptor b (IL2RB) was identified as the candidate gene for the 22q12 locus (Bucheton et 
al., 2007). 
In Iranian CL patients, it has been suggested that the risk of developing CL could be 
influenced by functional genetic variants in the IL-4 promoter while the polymorphism in the first 
intron of the IFN-gamma gene might influence the progression of disease towards Chronic CL 
(Kamali-Sarvestani et al., 2006). Similar role of L-10 has been found  in humans infected with L. 
braziliensis (Salhi et al., 2008). 
Vector Factors 
Sand-fly saliva consists of roughly thirty different salivary proteins, some are linked to 
blood feeding facilitation and several have been shown to be immunogenic (Gomes and Oliveira, 
2012). The saliva modulates both the innate and the acquired host immune responses (Rohousova 
and Volf, 2006) and induce positive macrophage chemotaxis (Zer et al., 2001) 
Hosts including humans repeatedly exposed to uninfected sand fly bites develop antibodies 
against the sand fly saliva as well as cellular response (Barral et al., 2000; Rohousova et al., 2005; 
Gomes and Oliveira 2012). High levels of anti-saliva IgG, specific to the local sand fly species has 
been documented in people living in endemic areas of Leishmaniasis in Brazil and Turkey. 
However, the frequency and intensity of salivary proteins recognitions varied among individuals 
(Rohousova et al., 2005). The presence of antibodies to salivary proteins from sand fly vectors of 
VL has been correlated with protection in humans (Gomes et al., 2008; Aquino et al., 2010) and in 
dogs (Vlkova et al., 2011). 
Two sand fly species have been studied for their salivary immunomodulatory properties, the 
Lutzomyia longipalpis and Phlebotomus papatasi (Rohousova and Volf, 2006). Studies 
demonstrated that these two genera could stimulate common as well as  specific host immune 
responses (Rohousova and Volf, 2006). L. longipalpis saliva / maxadilan (vasodilator peptide) 
modulates the secretion of various cytokines and alters the expression of co-stimulatory molecules. 
In human it decreases the secretion of TNF-α and IL-10 and increases the levels of IL-6, IL-8, and 
IL-12p40 (Rogers and Titus, 2003; Costa et al., 2004). Changes in the expression of co-stimulatory 
molecules can alter the T-cell activation and response (Qureshi et al., 1996; Costa et al., 2004), 
however, the intensity of the stimulatory and inhibitory effects varies depending on the individuals 
(Costa et al., 2004). Similarly to L. longipalpis, the saliva of P. papatasi has an inhibitory effect on 
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lymphocyte proliferation. It suppresses early production of IL-2, IL-4, and IFN-γ (Rohousova and 
Volf, 2006)  and increases production of IL-6 (Rogers and Titus, 2003) and differently from L. 
longipalpis, P. papatasi saliva shows  three important species-specific modulations: it  has no effect 
on TNF-α production  by LPS-stimulated human monocytes (Rogers and Titus, 2003), it down-
regulates the expression of inducible NO synthase (iNOS)  and subsequent production of  NO in 
LPS- or IFN-γ-activated murine macrophages and thirdly, it  up-regulates  the expression of the Th2 
cytokine IL-4 (Mbow et al., 1998),thus preventing the development of inflammatory response.  
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PART TWO 
Molecular Genetic approach in Leishmania 
 
2.1  Leishmania Genome 
The Leishmania genome is composed of the nuclear genome and the kDNA, which is the 
mitochondrial DNA of the Kinetoplastida. kDNA constitutes 10–20% of the total DNA of 
Leishmania and can be divided into two classes: the heterogeneous minicircles and the homogenous 
maxicircles.  The minicircles have been shown to encode guide RNA (gRNA) molecules involved 
in the RNA editing of maxicircle cryptogenes (Simpson, 1987; Sturm and Simpson, 1990). 
The L.major nuclear genome which sequenced in 2005 (Ivens et al., 2005), has provided a 
framework for future comparative genomic studies of other two Leishmania species, L.braziliensis 
and L.infantum, in 2007 (Peacock et al., 2007). Comparative genomic studies of these three species 
identified more than 8,300 protein-coding genes and 900 RNA genes (Peacock et al., 2007). Many 
genes remain unclassified (approximately 69%), with 40% of these being potentially Leishmania- 
(or kinetoplastid) specific (Myler and Stuart, 2000). Summary of the three Leishmania species 
genomes shown in table 2 
Leishmania conserves about 6,200 trypanosomatid genes and has more than 1,000 
Leishmania-specific genes, most of them uncharacterized (Peacock et al., 2007). Unlike 
Trypanosomes, Leishmania chromosomes have not extended subtelomeric regions containing 
species-specific genes (Peacock et al., 2007). 
 
2.2  Gene Organization and Genome Content 
Genome plasticity, variation in chromosomal content and of chromosome size even between 
homologous chromosomes is characteristic for each Leishmania species (Blaineau et al., 1991; 
Sterkers et al., 2012).  
Leishmania is considered to be a diploid organism (Iovannisci et al., 1984), however, 
evidences suggest that all Leishmania species are naturally aneuploidy (Rogers et al., 2011; 
Mannaert et al., 2012). Aneuploidy is often associated with drug pressure and with parasite 
adaptability to the host environment (Mannaert et al., 2012).  Drug pressure due to the treatment of 
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infected patients between whom the parasites are transmitted may be the cause of the extreme 
chromosome copy number variations in L. donovani (Mannaert et al., 2012). 
Genes are organized into directional clusters, which are either polycistrons (PGCs) or groups 
of genes sharing uncharacterized regulatory elements (Peacock et al., 2007). Old World  
Leishmania species (L. donovani/infantum, L. major and  L. tarentolae) have 36 chromosomes. Due 
to unique chromosome fusion events, L. braziliensis has 35 chromosomes and   L. mexicana has 
only 34 chromosomes (Table 2).  
 
  L. major  L. infantum  L. braziliensis  
Chromosome number 36 36 35 
Size (bp) 32,816,678 32,134,935 32,005,207 
Contigs 36 562 1,041 
Overall G+C content (%) 59,7 59,30 57.76 
Coding genes  8,298 8,154 8,153 
Pseudogenes 97 41 161 
Coding G+C content (%) 62,5 62,45 60,38 
 
Table 2: Summary of the L. major, L. infantum and L. braziliensis genomes (Peacock et al., 2007). 
 
2.3  Genes and Leishmania Parasite Tropism and Virulence 
The comparative genomic studies of the three leishmania species (L.major, L.braziliensis 
and L.infantum) revealed that only few species-specific parasite genes are important in pathogenesis 
and  that parasite gene expression levels differ considerably between species This may be attributed 
to the variation in gene copy number (Peacock et al., 2007). Beside the two groups of parasite 
molecules that are thought to be involved in Leishmanial mechanisms of virulence, i.e the invasive/ 
evasive determinant and the pathoantigens (Chang et al 2002) which have been mentioned 
previously in section 1.9.2, other genes and loci associated with clinical polymorphism but not 
directly involved in virulence or pathogenicity were explored and known as the Indirect Genetic 
Markers (Bañuls et al., 2007). Few of the Indirect Genetic Markers were found to be associated 
with clinical phenotypes at the intraspecific level, however, they are able to distinguish the different 
species and reveal intraspecific polymorphism (Bañuls et a.,l 2007). 
Gene Families 
Trible “Marcov Cluster algorithm (MCL) of the L.major strain Friedlin (LmjF) predicted 
protein sequences “which is an algorithm used to assignment of proteins into families basing on 
pre-computed sequences similarity information” (Enright, et al., 2002) revealed 662 gene families  
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containing 3,083 sequence (Ivens et al., 2005). Smaller gene families consist of tandem arrays of 
one to three genes including large number of gene duplications particularly for ribosomal proteins 
and translation initiation factors. Members of the large gene families may be found in tandem arrays 
as well as dispersed throughout the genome. The largest protein families include among others 198 
kinesin-related protiens, 60 protien kinases, 46 amastins, 32 GP64 and 29 RNA helicases (Myler P 
J,  Fasel N, 2008). 
  RNA Genes 
In LmjF genome 1,000 genes encoding structural RNAs were identified. The presence of 
approximately 24 copies of the rRNA unit per diploid genome in LmjF has been suggested 
(Martinez-Calvillo et al., 2001). There is a tandem array of 18S, 5.8S and 28S ribosomal RNA 
genes on chromosome 27 while the 5.8S rRNA are found as dispersed single copies in different loci 
on different chromosomes. LmjF genome contains 83 tRNA genes and six snRNAs. The 
rRNA genes of L. donovani are organized on chromosome 27 as tandem repeats (Yan et al., 1999). 
Repetitive Sequences 
Unlike other trypanosomatids, Leishmania genome contains relatively little repetitive 
sequences (< 10%) composed of tandem arrays of protein-coding and RNA genes (Myler P J,  Fasel 
N, 2008). 
Species- Specific Differences 
Genome wide comparison studies of the three Leishmania species (L.major, L.braziliensis and 
L.infantum ) revealed that sequence preservation between species is high (Peacock et al., 2007). 
Only few species-specific parasite genes are found, 5 in L.major, 26 in L.infantum and 47 in 
L.braziliensis. Another 32, 6 and 98 genes respectively are absent from L.major, L.infantum and 
L.braziliensis, in the last case species- specific differences attributable to pseudogene formation 
(Myler P J,  Fasel N, 2008). 
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Leishmaniasis in Sudan 
3.1  Introduction 
Sudan is known as one of the most endemic areas of leishmaniasis in the world. The disease 
represents a serious health problem and outbreaks occur periodically causing high number of 
victims (Zijlstra et al., 1994; Osman et al., 2000; Khalil et al., 2008). Worth to mention that Sudan 
has splitted into two independent states which are the Republic of Sudan (RoS) and the Republic of 
South Sudan (RoSS). Leishmaniasis is endemic in both states. The RoSS witnesses ongoing VL 
outbreak.  
Many different clinical forms of leishmaniasis co-exist. The most serious VL is caused by 
Leishmania donovani complex and transmitted by Phlebotomus orientalis (Elnaiem et al., 1998a; 
Zijlstra and el-Hassan, 2001a). VL is endemic in the Eastern part of the country (el-Hassan et al., 
1995; Khalil et al., 2002) (map 9), however scattered cases have been reported from areas not 
known to be endemic in the Southern, Northern and Western parts (Osman et al., 2000). Both 
anthroponotic and zoonotic transmission are thought to occur (Zijlstra et al., 1994; Zijlstra, el-
Hassan, Ismael, 1995; Elnaiem et al., 2001; Dereure et al., 2003; Hassan et al., 2004). 
CL in Sudan is caused by L.major and transmitted by P.papatasi. However, CL due to L. 
donovani has been well documented (Elamin et al., 2008). The disease is endemic in the central and 
northern part (el-Safi and Peters, 1991; el-Hassan and Zijlstra, 2001) (map 10). Generally, the CL in 
Sudan is believed to be zoonotic as in other endemic areas in the world where the CL is due to L. 
major. The Nile rat  Arvicanthis niloticus  has been suggested  as reservoir (Salah Eldin., 1997). 
Knowledge on the sandflies fauna and the animal reservoir host of CL due to L.donovani is still 
lacking. 
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Map 6: Distribution of visceral and cutaneous leishmaniasis in Sudan and South Sudan 
(Zijlstra and el-Hassan, 2001) 
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Map 7: Distribution of CL due to L.major in Sudan: (el-Hassan and Zijlstra, 2001) 
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PKDL occurs in high rate during or shortly after treatment. At least 50% of VL patients 
develop PKDL, and this percentage is higher than in any other VL endemic area (WHO, 2010) 
(Zijlstra et al., 1995; Zijlstra et al., 2003). PKDL patients are thought to act as human reservoir for 
the parasite (El Hassan and Khalil, 2001). 
Sudanese Mucosal Leishmaniasis (SML) is a rare and particular form of ML. Unlike ML, 
SML starts usually as primary mucosal disease, without being preceded or accompanied by 
cutaneous lesions. SML occurs in areas endemic for VL (el-Hassan et al., 1995). Few sporadic 
cases of ML have been reported in Sudan (map 11).  Most of these cases were from endemic areas 
of VL. Isoenzyme characterization identified that L.donovani zymodeme MON 18 isolated from 
ML patients is the same that causes VL in the Western  Upper  Nile  Province  and  among  the  
Misairriya  tribe  in Kordofan (el-Hassan et al., 1994; el-Hassan et al., 1995). 
Map 8: Distribution of known cases of mucosal leishmaniasis in Sudan (el-Hassan et al., 
1995). 
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Leishmania/HIV co-infection is a growing concern particularly in the East (Alvar et al., 
2008). The first case of AIDS was reported in 1986, and in December 2006 the adult national 
prevalence rate was 1.6 %, indicating that Sudan is in a generalized epidemic (Alvar et al., 2008). 
The transmission is mainly heterosexual, however vertical transmission from mother to child also 
play a role. 
The most affected areas are Khartoum and the Eastern and Southern states, likely due to population 
movements (refugees and internally displaced populations) (Alvar et al., 2008). 
 
3.2  Sand Flies in Sudan and South Sudan 
Nine Phlebotomus species and 37 Sergentomyia species have been identified (map 12). 
Phlebotomus sandflies in the Sudan include  P. orientalis, P. papatasi, P. martini, P. rodhaini, P. 
pedifer, P. alexandri, P. saevus, P. bergeroti and P. duboscqi (Elnaiem, Hassan, Ward, 1997; 
Lambert et al., 2002). 
Map 9: Sand Flies in Sudan and South Sudan (el-Hassan and Zijlstra, 2001)  
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Out of these species only two are thought to play a major role in disease transmission in Sudan, P. 
orientalis, the proven vector of  VL (Elnaiem et al., 1998b; Jamjoom et al., 2004), and P. papatasi, 
the proven vector of CL (Desjeux P, 1991; El-Sayed S M. 1990). P. martini has been incriminated 
as a vector of  VL in Southern Sudan (Ashford et al., 1992).  P. rodhaini is not known as a vector, 
but it was found infected with L. donovani in woodland of Dindir National Park. Later, this sandfly 
has been found in the Northern part of Sudan (Hassan et al., 2007) and was thought to play a role in 
maintaining the zoonotic cycle among reservoirs (Hassan et al., 2007). 
P. orientalis and P. papatasi are known as seasonal species (Hoogstraal et al.,1962; 
Hoogstraal and Dietlein., 1964). The two species start to appear immediately after the rainy season 
(late October) and disappear during the rainy season (July-October) (Elnaiem et al., 1998b; Elnaiem 
et al., 2003). P. orientalis is mainly associated with Acacia seyal / Balanites aegyptiaca, vegetation 
that grows on black cracking clay soil in Eastern and Southern Sudan (Elnaiem et al., 1998b). 
Unexpectedly, it was found in semi-arid areas in Northern Sudan (Hassan et al., 2007). Its 
distribution is influenced by certain climatic and ecological determinants (Elnaiem et al., 1998b). P. 
orientalis was found to be attracted more to dog baited traps than Mongoose, Genet and Nile rat 
(Hassan et al., 2009). In endemic areas in the Eastern Sudan, in-village transmission is highly 
suggested because infected P. orientalis were reported from these villages (Hassan et al., 2004). 
P.papatasi occupies arid areas of semi-desert, desert and Savannah region. It was collected 
up to the north. P. papatasi is collected from woodland of Dindir National Park, 45 km from a 
nearest village. Also, it was collected from Savannah area in the south and eastern Sudan (El-Sayed 
S M. 1990). 
 
  3.3  The Leishmania Reservoir in Sudan 
The Nile rat Arvicanthis niloticus is the probable reservoir of CL (el-Hassan and Zijlstra, 
2001), while rodents and dogs were initially selected as the most probable reservoir hosts of a 
zoonotic L. donovani cycle (Elnaiem et al., 2001; Hassan et al., 2009). Rodents were particularly 
suspected, as they are the most abundant and widely dispersed animals of the local mammal fauna 
(Hoogstraal and Dietlein.,1964). Few further studies and researches have been conducted to update 
the state, but incrimination of rodents remains inconclusive. 
Infected carnivores were found, i.e. the Senegal genet (Genetta g. senegalensis) and the 
Sudanese serval (Felis serval phillipsi) of the cat family (Felidae) (Hoogstraal and Dietlein., 1964). 
The wild jackal Canis adustus was the most common wild carnivore in the area, but these animals 
were not found infected. Infection of wild carnivores may have been acquired by consuming 
infected rodents or through bites of sand flies (Hoogstraal and Dietlein., 1964). 
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Domestic dogs are abundant, Dereure et al suggested that dog may play the role of the 
reservoir of VL in Sudan or it may acts as a bridge host between a possible sylvatic cycle and the 
anthroponotic cycle (Dereure et al., 2000; Dereure et al., 2003). More extensive studies are needed 
to assess the transmission cycle of VL in Sudan. 
The zoonotic transmission of both CL and VL remain inconclusive, however different 
animals were suggested to act as reservoir such as the Nile rat (Arvicanthis niloticus), the common 
african rat (Mastomys natalensis), the egyptian mongoose (Herpestes ichneumon), the domestic dog 
(Canis familiaris), the genet (Genetta genetta),  the jackal and serval cat (Hoogstraal and Dietlein., 
1964; Elnaiem et al., 2001; Hassan et al., 2009). 
 
3.4  Control, Diagnosis and Treatment of Leishmaniasis in Sudan 
Since 2001, the leishmaniasis control program has been merged with the Malaria and 
Schistosomiasis control program under the National Malaria, Schistosomiasis and Leishmaniasis 
administration within the Division of the Endemic Disease Control created by the Federal Ministry 
of Health. The organization Médecins Sans Frontières Holland (MSF-H) has been involved in the 
VL control program since its first response to an outbreak in Gedarif state in eastern Sudan in 1996. 
From 2001 to 2004, MSF–H supported five hospitals in Gedarif state and two hospitals in Sennar 
State to improve diagnosis and treatment and to introduce a surveillance system for HIV/VL co-
infection. In 2010 Médecins Sans Frontières Suisse (MSF CH) has started to support Tabarak Allah 
hospital in Gedarif state through diagnosis, treatment and medical follow up (WHO, 2010). 
The national diagnosis guidelines recommend the use of rK39 and DAT for VL diagnosis in 
the field. Parasitological confirmation via a lymph node or bone marrow aspirate is recommended. 
MSF CH uses the rK39 and DAT for diagnosis of primary VL, and lymph node aspirates in cases of 
relapse and for test of cure (WHO, 2010). 
The first line treatment of VL is the SSG for 30 days or Glucantime (meglumine 
antimoniate) for 21 days. Second line treatment is AmBisome (liposomal amphotericin B) (WHO, 
2010). Combination therapy of  SSG/ paromomycin has also been used as an alternative second line 
treatment (WHO, 2010). Amphotericin B is not recommended due to possible side effects while 
Miltefosine is planned to be included (WHO, 2010). SSG is used for treatment of long persisting 
PKDL (more than 6 months) or sever cases (WHO, 2010). 
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3.5  Rationale of the Study 
The genus Leishmania includes many pathogenic species which have the ability to adapt and 
survive in very diverse environments encountering strong selection pressures (biotic as well as 
environmental) and infecting a large range of mammalian hosts and sand fly species (Bañuls et al., 
2007). Leishmania species revealed a high degree of genetic diversity resulting in different 
phenotypes and pathogenic potentiality (Cupolillo et al., 1998; Herwaldt, 1999; Cunningham, 
2002). Paradoxically, different types of diseases are sometimes caused by the same Leishmania 
species group while the same phenotype of the disease may be caused by different Leishmania 
species. The mechanisms by which Leishmania parasite cause different pathologies are largely 
unknown. 
Experimental studies demonstrated that different strains of different Leishmania species are 
attributable to differences in disease expression and immune responses (Bañuls et al., 2007 ) and 
that differential degrees of polymorphism exist within a single species among geographical location 
or host (vector or reservoir) (Bañuls et al., 2007). Moreover, the considerable overlap in clinical 
manifestations and the  uncommon disease phenotypes (Elamin et al., 2005), the mixed infection 
with different strains or species of Leishmania and its impact on disease diagnosis, prognosis  and 
the consequent drug resistance (Antoniou et al., 2004) highlight the need to unravel the genetic 
diversity at the inter- and intra-specific level and strain typing. In parasitic diseases, strain typing 
becomes a basic tool for taxonomic, epidemiologic as well as medical studies (Nadler, 1995).  
To build up a reliable picture of the various phylogenetic subdivisions with relation to 
virulence, genes such as the ribosomal ribonucleic acid genes, the Lyshmanolysin (GP63) and the 
cytochrome Oxidase become indispensable. 
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3.6  Hypotheses 
Genetic polymorphism at the Inter and intra specific level might be associated with disease 
phenotype. 
3.7  Objectives of the Study 
General Objectives 
To understand the correlation between the genetic diversity and the clinical 
manifestations. 
Specific Objectives 
To genetically characterize isolates from Sudanese patients diagnosed with different 
types of leishmaniasis to understand the correlation between different clinical 
manifestations and the genetic profile of Leishmania. 
Investigate presence or absence of mixed infections and/ or hybrids. 
To build up a reliable picture of the various phylogenetic subdivisions with relation to 
virulence, using the Internal Trascribed Spacer (ITS) gene, the Lyshmanolysin 
(GP63) and the cytochrome Oxidase sub- unit II gene. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER TWO 
 
 
MATERIALS AND METHODS 
 
 
 
 
 
 
 
 
 
 
 
 
36 
 
Materials and Methods 
2.1  Ethical Consideration 
This study was approved by the ethical committee of the Institute of the Endemic Diseases, 
University of Khartoum and by the Ethical review Board at the Federal Ministry of Health, Sudan. 
The biological human samples were taken during a routine diagnostic service and no additional 
samples were required for this study. 
 
2.1  Study area 
This study was carried out in an endemic focus of visceral leishmaniasis (VL) in Gedarif 
State, Eastern Sudan (411 km from Khartoum). The study area is composed of clusters of villages 
where the disease is well known among inhabitants as kala-azar (Figure 7). The area is flat and 
composed of cracked alluvial clay soil characterized by tropical climate, i.e. a dry hot summer 
(March-June) with average temperature range of 28-44
o
C, warm wet autumn (July-October) and 
moderately warm winter (November-February) with average temperature range of 18-34
 o
C. The 
annual rainfall is about 600mm. Large scale rain fed sorghum and sesame fields surround the 
villages. Inhabitants mainly work as farmers, woodcutters and shepherds. Many nomadic tribes 
roam the area. 
 
Figure 7:  the Study area 
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2.2  Samples Collection 
One hundred and eleven samples composed of blood (HB), bone marrow (HBM), lymph 
node aspirates (HLN), extracted DNA and cultured parasites were obtained from 72 patients 
clinically suspected of Leishmaniasis. Samples collection occurred in periods between 14-25 
December 2010 and 10 -20 January 2012. 
  VL Biological Samples 
From 21 patients, HBM, HB and HLN aspirates were available. Seven HB samples and one 
HLN were collected from eight symptomatic VL patients at MSF-CH Leishmaniasis clinic inside 
the local Tabarak Allah hospital (Gedarif, Sudan). Other 20 HB and 5 HMB were collected from 
south Gedarif outpatient clinic (Table 3). Clinical samples were spotted on Whatman filter paper 
#3; each filter paper sample was stored in a separate polyethylene bag at room temperature till 
further analysis. 
CL Samples 
Eight samples were taken from eight patients presented at IEND with typical CL ulcers and 
attempted for culture (Table 3). 
Extracted DNA 
 Ten extracted genomic DNA of seven VL, one CL, one ML and one PKDL were kindly provided 
by the IEND (Table 3).  
Leishmania Reference strain 
L.major MON 25, L.tropica MON 30 kindly provided  by the Leishmania Reference Centre, 
Italy and L.infantum MON 1 MHOM/TN/80/IPT1 kindly provided  by the IZSVe were included in 
this study. 
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Table 3: Provenance, numbers and types of samples collected included in the study. HBM : Human Bone 
Marrow, HB: Human Blood, HLN: Human Lymph Node. .IEND: Institute of Endemic Diseases. 
*: samples from same patients 
 
2.3 Molecular Assay 
Parasite Isolation and Culture Condition 
Leishmania parasites were isolated as described by Evans (1989) using a modified biphasic 
NNN media consisting of solid and liquid phases. The solid phase was prepared by dissolving 2.5 
gm blood agar base into 100 ml distilled water, the mixture was then boiled, autoclaved and cooled 
to 50 °C. Defibrinated rabbit blood was then added in a concentration of 10%. The media were 
melted in sterile glass tubes that laid in a slope position till the agar solidification. The tubes were 
incubated at 4°C for 24 hours. The liquid phase composed of 10% FCS and 90% RPMI 1640 was 
added just before use. Penicillin / Streptomycin mix (5 U/ ml) or Gentamycin (25ug/ml) were added 
to the media. 
Cutaneous Isolates : A single cutaneous aspirate from the edges of the ulcer of each CL suspected 
patient was inoculated into the bottles containing biphasic media (NNN) and incubated at 24°C . 
Cultures were examined microscopically for parasite growth or contamination on the third day. 
DNA of successfully cultured isolates was extracted. No mass cultures was done.  
Other IEND Isolates:  The  parasite isolation of the ten extracted genomic DNA (seven VL, one 
CL, one ML and one PKDL) was performed as in cutaneous isolates mentioned above but mass 
cultures were carried out. When parasite growth was established, the isolates were sub-cultured into 
a sterile RPMI 1640 containing 25 HEPES (pH 7.4), 10% heat inactivated FCS, streptomycin and 
penicillin at 5U/ml (complete media). Cultures were grown in sterile 25 ml flasks and incubated at 
26°C.  About 200 µl of growing Leishmania isolates were sub-cultured into 10 ml of complete 
Geographic origin Sample 
Type 
Number of 
samples 
Leishmaniasis 
diagnosis 
Clinical  
Manifestation 
 
Central Gedarif city  
HBM* 
HB* 
HLN* 
21 
21 
18 
symptomatic 
symptomatic 
symptomatic 
VL 
VL 
VL 
 TabarakaAllah H HB 
HLN 
7 
1 
serological 
serological 
VL 
VL  
South Gedarif city  HBM 
HB 
5 
20 
symptomatic 
symptomatic 
VL 
VL 
 
Khartoum-IEND 
 
DNA 
DNA 
DNA 
DNA 
7 
1 
1 
8 
culture 
culture 
culture 
culture 
VL  
PKDL  
ML  
CL  
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media and incubated at 26°C for one week when the stationary growth phased reached. The cultures 
were transferred into 15 ml sterile tubes and centrifuged at 3000 rpm for 10 minutes, the pellets 
were used for DNA extraction. 
 
2.3.2 DNA Extraction  
DNA extraction from culture 
DNA of the cultured parasites was extracted in the IEND laboratory using 
phenol/chloroform method as described elsewhere (Maniatis et al., 1986) with few modifications. 
Briefly, promastigotes were collected by centrifugation at 3000 rpm for 15 minutes. The Pellets 
were washed three times with 1× PBS buffer, detached and incubated at 55°C overnight with 5ml 
lysis buffer (NaCl 50mM, EDTA 10 mM, tris HCl 50 m M), 25 µl of 10 % SDS (w/v) and 100 µl of 
proteinase K. On the second day, 5ml of phenol were added, mixed gently and centrifuged for 15 
minutes at 3000 rpm at 4°C, the upper layer was transferred into a new clean 50 ml tube, 2.5ml 
phenol and 2.5 ml chloroform- isoamyl alcool were added, mixed well then centrifuged as above, 
again the upper layer was transferred into a new clean 50 ml tube, 100 µl RNAse (29 ug/ml) was 
added, mixed and then incubated for 2 hours at 37°C. 2.5ml phenol and 2.5 ml chloroform- isoamyl 
alcool were added, mixed and centrifuged and treated as previously (this step could be repeated 
until the interphase disappears), thereafter, 10 ml of absolute ethanol was added and mixed. The 
tubes were then incubated at -20°C for one hour, after that the tubes were centrifuged as previously 
and the supernatants were discarded. The volume was brought to 10 ml with 70% cold ethanol, 
mixed gently and centrifuged for 10 minutes. The supernatants were discarded and the tubes were 
allowed to dry for about 40 minutes, 300 µl of TE buffer or distilled water were added, mixed 
gently and incubated overnight at room temperature. The next day the DNA was transferred to a 
sterile 1.5 ml eppendorf tube and stored in - 20°C till transferred to the parasitology laboratory in 
the IZSVe premises. 
 
DNA Extraction From Clinical Samples Spotted on Filter Papers 
 Extraction took place at the parasitology laboratory in the IZSVe premises. Filter papers 
with spotted biological material (Lymph node and bone marrow aspirates or blood) were punched 
out with a paper puncher. To prevent DNA contamination among samples, clean sheet of paper 
sprayed with MicroSol 3+ TM solution was punched several times. DNA extraction was performed 
using QIAamp DNA Mini Kit according to manufacturer’s instructions. Briefly, 3 to 6 punched-out 
circles (about 3mm diameter) from a dried biological spot  were placed into a 1.5 ml micro- 
centrifuge tube, 180 μl of Buffer ATL was added, the mixture was then incubated at 85°C for 10 
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minutes then centrifuged to remove drops from inside the lid, 20 μl proteinase K stock solution was 
added,  mixed by vortexing, and thereafter incubate at 56°C for one hour. 200 μl Buffer AL were 
added to the sample, mixed thoroughly and incubated at 70°C for 10 min. After that 200 μl ethanol 
(96–100%)  were added to the sample, mixed thoroughly. The mixture thereafter was applied to the 
kit Mini spin column (in a 2 ml collection tube), centrifuged at 8000 rpm for one minute, the Mini 
spin column was then placed in a clean 2 ml collection tube while the filtrate was discarded, after 
that 500 μl Buffer AW1 were added, centrifuged at 8000 rpm for 1 minute, again the Mini spin 
column was placed in a clean 2 ml collection tube and the filtrate was discarded. 500 μl Buffer 
AW2 were added and the mixture was centrifuged at maximum speed for three minutes, the Mini 
spin column was then placed  in a clean 1.5 ml micro-centrifuge tube  and the collection tube 
containing the filtrate was discarded. 150 μl Buffer AE was added, incubated at room temperature 
for 1 minute, and then centrifuge at  8000 rpm for another minute. 
2.3.3  Real Time PCR  Assay 
As an initial screening, a real time PCR was conducted to investigate the presence of 
Leishmania complexes (L. viannia, L. mexicana, L. donovani/infantum, and L. major) in all 
samples. The primers Lid-f and Lid-r which generate a 80bp fragment of the GPI gene (Wortmann, 
et al., 2005) were used with the probe TaqMan MGB Lid-probe labelled with the fluorescent 
reporter dye FAM (6-carboxyfluorescein) at the 5’end and with the fluorescent quencher dye 
TAMRA (tetra-methyl carboxyrhodamine) (Primers and probe sequences are shown in Table 4). 
Real time PCRs were performed in a final volume of 20 μl containing 3 μl of DNA, 10 μl of 
FastStart TaqMan Probe Master (Rox)1X (Roche Mannheim, Germany), 0.4 μM of both primers 
and 0.3 μM of the probe. The thermal cycling profile consisted of an initial activation at 95°C for 10 
min, followed by 45 cycles each consisting of denaturation at 95°C for 15sec and 
annealing/extension at 60°C for 30sec. Negative (sterile water) and positive (DNA extracted from 
L. infantum MON-1, MHOM/TN/80/IPT1, IZSVe-Italy) controls were included in each run of real 
time PCR reaction. Real time PCR was carried out on a 7900HT fast Real-time PCR system 
(Applied biosystems). 
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2.3.4  Polymerase Chain Reaction (PCR) 
kDNA PCR  
Fifty Real Time PCR  positive samples were tested by two PCRs, using the two couple of 
primers AJS3/R1 and F2/DBY (Lambson et al, 2002) which amplify respectively a 620 bp and 250 
bp fragments of the kDNA gene  
 
     AJS3                                    F2                                 DBY 
      
                                                          
                                                       R1                                
  
         Figure 8: The DNA segments of the selected minicircle kDNA class used for amplification.  
 
The two PCRs had the same amplification conditions. The reactions were performed in a 
final volume of 50 µl containing 5 µl of DNA, 5 µl of PCR buffer 1X (Applied Biosystems, Foster 
City, CA), 2 mM of MgCl2 (Applied Biosystems, Foster City, CA), 0.5 µM of each primer, 0.2 mM 
of dNTPs (Applied Biosystems, Foster City, CA), 2 U of AmpliTaq Gold DNA polimerase 
(Applied Biosystems, Foster City, CA). Amplifications were carried out in a GeneAmp®PCR 
System 9700 thermal cycler (Applied Biosystems, Foster City, CA) with the following thermal 
cycling profile: denaturation for 10 min at 95°C, followed by 35 cycles each consisting of 30 sec at 
94°C, 30 sec at 63°C, 30 sec at 72°C and a final extension step for 7 min at 72°C.  Negative and 
positive controls were included in each run of PCR. PCR products were analysed on acrylamide gel, 
visualized and subsequently subjected to sequencing. 
 
Cytochrome Oxidase II gene PCR 
PCR was performed as described previously for the targeted Cytochrome Oxidase II 
(Abdalla Hassan Sharief et al., 2011) for all Leishmaniasis Real Time PCR positive samples. 
(Primers sequences were shown in table 2). The reaction was performed in a final volume of 50 µl 
containing 5 µl of DNA, 5 µl of PCR buffer 1X (Applied Biosystems, Foster City, CA), 2 mM of 
MgCl2 (Applied Biosystems, Foster City, CA), 0.4 µM of each primer, 0.2 mM of dNTPs (Applied 
Biosystems, Foster City, CA), 2 U of AmpliTaq Gold DNA polimerase (Applied Biosystems, 
Foster City, CA). Amplifications were carried out in a GeneAmp®PCR System 9700 thermal cycler 
(Applied Biosystems, Foster City, CA) with the following thermal cycling profile: denaturation for 
10 min at 95°C, followed by 35 cycles each consisting of 30 sec at 94°C, 30 sec at 50°C, 45 sec at 
72°C and a final extension step for 7 min at 72°C.  Negative and positive controls were included in 
each run of PCR as described above. PCR products were analysed on acrylamide gel, visualized and 
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subsequently subjected to sequencing. Three sequences associated with cutaneous samples showed 
overlapping nucleotides peaks. These samples had been subjected to cloning. 
 
Internal transcribed Spacer (ITS) PCR  
The ITS PCR was performed in 10 samples. The ITS region (1044pb nucleotides) was 
amplified with the Leishmania specific primers: LITSR (El Tai et al., 2000) and a new designed 
primer LITSRR (Table 4). The new primer was necessary to include L. donovani complex and L. 
major. Multiple alignments of GenBank related DNA sequences of different L. donovani complex 
and L. major species  were gathered  using the database search tool developed by the National 
Center for Biotechnology Information (NCBI: (http:// www.ncbi.nlm.nih.gov/). Sequences were 
aligned using the ClastalW alignment program implemented in Mega 5. The reverse primer was 
designed in a conserved region among sequences that preceded a variable region respecting the 
melting temperature of the existing forward primer. 
The reaction was performed in a final volume of 50 µl containing 0.5 µl of DNA, 5 µl of 
PCR buffer 1X (Applied Biosystems, Foster City, CA), 2 mM of MgCl2 (Applied Biosystems, 
Foster City, CA), 0.4 µM of each primer, 0.2 mM of dNTPs (Applied Biosystems, Foster City, CA), 
2.5 U of AmpliTaq Gold DNA polimerase (Applied Biosystems, Foster City, CA). Amplifications 
were carried out in a GeneAmp®PCR System 9700 thermal cycler (Applied Biosystems, Foster 
City, CA) with the following thermal cycling profile: denaturation for 10 min at 95°C, followed by 
35 cycles each consisting of 30 sec at 94°C, 30 sec at 50°C, 1 minute at 72°C and a final extension 
step for 10 min at 72°C.  Negative and positive controls were included in each run of PCR as 
described above.The PCR products were cloned after being analysed on acrylamide gel and 
visualized. 
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GP63 PCR 
Twenty five Real Time PCR positive samples were tested using the two couple of primers 
gp63-1/gp63-2 and gp63-3/gp63-4 (El Tai et al, 2001), which amplify respectively a 442 bp and 
374 bp fragments of the gp63 gene  
 
Figure 9: The two DNA segments of the GP63 gene selected for amplification. 
 
The same amplification conditions were used for the two PCRs. The reactions were 
performed in a final volume of 50 µl containing 5 µl of DNA, 5 µl of  PCR buffer 1X (Applied 
Biosystems, Foster City, CA), 2 mM of MgCl2 (Applied Biosystems, Foster City, CA), 0.4 µM of 
each primer, 0.2 mM of dNTPs (Applied Biosystems, Foster City, CA), 2.5 U of AmpliTaq Gold 
DNA polimerase (Applied Biosystems, Foster City, CA). Amplifications were carried out in a 
GeneAmp®PCR System 9700 thermal cycler (Applied Biosystems, Foster City, CA) with the 
following thermal cycling profile: denaturation for 10 min at 95°C, followed by 35 cycles each 
consisting of 30 sec at 94°C, 30 sec at 64°C, 1 min at 72°C and a final extension step for 7 min at 
72°C.  Negative and positive controls were included in each run of PCR, PCR products were 
analysed, visualized and subsequently subjected to sequencing as will be described. Some 
sequences showed overlapping nucleotides peaks, six were subjected to cloning. Unfortunately, 
gp63-5/gp63-6 PCR gave bad results, only fewer samples were amplified, these primers were later 
on abandoned. 
 
MSPC PCR 
PCR was performed in 4 samples. The ext region (1044pb nucleotides) (Mauricio et al, 
2007) was amplified with the forward  primer gp63-3 (El Tai et al., 2001) and a new designed 
primer gp63-7 (Ttable 4). The new primer was necessary to include longer sequences in the gp63 
EXT region, which is a single copy gene in L.infantum. As in the ITS reverse primer, the new 
primer was designed in a conserved region among different related GenBank sequences after  
multiple alignments using the ClastalW alignment program implemented in Mega 5. respecting the 
melting temperature of the existing forward primer. The reaction was performed in a final volume 
 
                                                     gp63-3                          gp63-4                                                    
                                                                                                                                  gp63-6 
gp63-1                                          gp63-2                            gp63-5                
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of 50 µl containing 5 µl of DNA, 5 µl of PCR buffer 1X (Applied Biosystems, Foster City, CA), 2 
mM of MgCl2 (Applied Biosystems, Foster City, CA), 0.4 µM of each primer, 0.2 mM of dNTPs 
(Applied Biosystems, Foster City, CA), 2.5 U of AmpliTaq Gold DNA polimerase (Applied 
Biosystems, Foster City, CA). Amplifications were carried out in a GeneAmp®PCR System 9700 
thermal cycler (Applied Biosystems, Foster City, CA) with the following thermal cycling profile: 
denaturation for 10 min at 95°C, followed by 40 cycles each consisting of 40 sec at 94°, 45 sec at 
62 °C, 2 minute at 72°C and a final extension step for 10 min at 72°C.  Negative (water) and positive 
controls (L.major ) were included in each run of PCR. Two PCR products that showed nucleotide 
overlapping were subjected to cloning. 
 
2.3.5  PCR Product Analysis 
Acrylamide Gel Electrophoresis 
20 µl of APS 10% were added to 5 ml of 7% Acrylamide in 15ml clean tube, 10 µl of 
TEMED were added, the mix was then poured into the previously prepared vertical electrophoresis 
cell and a comb of 10 or 15 wells was inserted into the cell and left 15-20 minutes for 
polymerization at room temperature. The assembled gel was placed in the electrophoretic chamber 
and overlaid with the running buffer (1× TBE), the comb was then removed  and wells were washed 
by the aid of a syringe, PCR products were loaded into wells by capillary tips after being mixed 
with loading dye in microtiter plate (2 -4 µl loading dye and 6-8 µl amplificate), suitable DNA 
marker (molecular ruler) was loaded also. The run was performed at 200V and 400mA for about 50 
minutes. 
 
Acrylamide Gel Staining and visualization 
After the end of the run, the gel was stained by Sliver Nitrate. The staining process consist 
of  adding the fixing solution (100 ml absolute ethanol and 15 ml of 65% nitric acid/1liter distilled 
water ) for ten  minutes followed by washing in distilled water for 5 minutes, after that 0.4%  
AgNO3 solution was added for 7 minutes and washed for 3 minutes, developing solution (Na2CO3 
activated by the addition of 750 µl of 36% formaldehyde) was added to visualize the band for 
maximum time of 3 minutes, after the development of the bands 5 % acetic acid solution was added 
for 5 minutes to stop the reaction. Gels were then washed by distilled water and closed into 
transparent plastic envelopes. 
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Sequencing Techinques and Sequence Analysis 
PCR products were sequenced using the Big Dye Terminator v3.1 cycle sequencing kit 
(Applied Biosystem, Foster City, CA, USA). The products of the sequencing reactions were 
purified using PERFORMA DTR Ultra 96-Well kit (Edge BioSystems, Gaithersburg, MD, USA) 
and sequenced in a 16-capillary ABI PRISM 3130xl Genetic Analyzer (Applied Biosystem, Foster 
City, CA, USA). Sequence data were assembled and edited with SeqScape software v2.5 (Applied 
Biosystem, Foster City, CA, USA). PCR products were sequenced at the  IZSVe.  
The homology analysis was performed using the NCBI BLAST program 
(http://www.ncbi.nlm.nih.gov/) and the software Mega 5 via alignment with sequences deposited in 
GenBank database (http:/ / www.ncbi.nlm.nih.gov/). 
Phylogenetic analysis of the sequences was conducted using MEGA 5 software program that  
enables to establish the robustness of the analysis through phylogenetic bootstrap test. The bootstrap 
test estimates the reliability and the topology of the created phylogenetic tree, determining the 
proportion of all possible trees that support each node. This ratio is expressed as a percentage and 
are considered statistically significant values greater than 70%. neighbor-joining method with 1000 
bootstrap replicates were used in the Phylogenetic analysis (Tamura et al., 2011).Phylogenetic 
analysis of the sequences was conducted by using the neighbor-joining method with 1000 bootstrap 
replicates implemented in MEGA 5 software (Tamura et al., 2011). Only sequences with more than 
750 bp were used for the phylogenetic analyses. 
Phylogenetic analysis of the sequences was conducted using MEGA 5 software program that  
enables to establish the robustness of the analysis through phylogenetic bootstrap test. The bootstrap 
test estimates the reliability and the topology of the created phylogenetic tree, determining the 
proportion of all possible trees that support each node. This ratio is expressed as a percentage and 
are considered statistically significant values greater than 70%. neighbor-joining method with 1000 
bootstrap replicates were used in the Phylogenetic analysis (Tamura et al., 2011). 
 
2.3.6 Molecular Cloning Assay 
The PCR products of three COII, 10 ITS, 6 gp63 short and 4 gp63 ext  genes were cloned 
separately into the PCR-II vector using a dual-promoter TOPO TA cloning kit (Invitrogen, 
Carlsbad, CA). Neb Turbo E. coli competent cells and S.O.C. Medium (New England biolabs) were 
used in the assay for increased flexibility. At least 20 randomly selected colonies from each PCR 
product were sequenced using the sequencing procedure described above. 
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Solid LB agar medium was prepared by adding  25 LB  medium capsules (MP Biomedicals, 
LLC, France) to 15grams BactoTM  Agar (Becton, Dickinson and Company, France) in 1 liter of 
distilled water, the mixture was then Autoclaved at 121 °C for 30 minutes in liquid cycle, cooled 
down to 60 °C and stored in 4 °C upon use, the solid medium was first liquefied in microwave for 
few minutes, then  50 μl  (100mg /ml)  ampicillin was added to 50 ml of the medium,  the mixture 
was then divided into 3 sterile Petri plates and allowed re-solidification. 80ul of X-gal (2%) was 
poured into each plate and spread evenly using a spatula, the plates were allowed to dry. The LB 
liquid media were prepared as the solid media but without the addition of the BactoTM  Agar, they 
autoclaved, cooled and stored the same way. The assay was composed of the following steps: 
Legation: The PCR products to be cloned were quantified by nanodrop 1000 3.7 (Thermo Fisher 
Scientific) to estimate the amount to be used in the ligation mix. 3 insert : 1 vector ratio was 
maintained.  The legation mix was made by adding 1µl of salt to the due µl of insert and of vector, 
the volume was then brought to 6 µl by adding distilled water. The legation mix was then left 5 
minutes at room temperature.  
Transformation: 5 µl of the legation mix were added to an iced- thawed NEB TURBO cell, the 
mixture was then left in ice for 30 minutes, thereafter the thermal shock  was done by immersing 
the tube into a hot water bath at 42 ° C for 30 seconds then again allowed 5 minutes in ice. The 
mixture was then added to 950 μl S.O.C contained in 15 ml tube and incubated at 37 ° C for one 
hour with light agitation. 
Plating: 100 µl, 300 µl and 600 µl of the incubated ligation mixture and the S.O.C medium were 
poured out onto the three prepared Petri plates containing the solid agar, X-gal and the antibiotics. 
The plates were incubated at 37 ° C for overnight. 
Colonies selection and preservation: Plasmids with the desired inserts (white colored colonies) 
were selected and put into 15 ml tubes containing 3 ml liquid LB and 3 µl ampicillin (100mg/ ml), 
the tubes were then incubated at 37 ° C for overnight. The day after, 800 µl of the culture were 
preserved into 200 µl of Glycerol and stored at -80 for future use, while the rest of the culture 
(about 1.2ml)  was transferred into 2ml Eppendorf tubes. 
Extraction:  Plasmids with the desired inserts were isolated from positive Escherichia coli colonies 
by using a GenElute plasmid miniprep kit (Sigma-Aldrich, St. Louis, MO). The final elution for 
some colonies was done with distilled water, in such cases the extracts were sent directly for 
sequencing. In the other colonies where the final elution was done with the kit elution solution, the 
extracts were first amplified by PCR and then sent for sequencing.  Sequencing and sequence 
analysis were carried out as mentioned above. 
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Table 4: sequences of primers used for detection and characterization of Leishmania 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gene Primer Name Sequence 
 
GP1 
Lid F 5’CCAGATGCCGACCAAAGC-3’ 
Lid R 5’CGCGCACGTGATGGATAAC-3’ 
TaqMan MGB  
Lid-probe 
5’TCGGCAGGTTCT-3’ 
 
kDNA 
AJ3 5’GGGTTGGTGTAAAATAGGG-3’ 
R1 5’TGCAGTATG CGCCAA 
CCTATA-3’ 
F2 5’ATAGGTTGG CGCATA 
CTGCAG-3’   
DBY 5’CCAGTTTCCCGCCCCGGAG-3’ 
 
Cytochrome Oxidase II 
COII F 5’GGCATAAATCCATGTAAGA-3’ 
COII R 5’TGGCTTTTATATTATCATTTT-3’ 
ITS LITSR (FOR)     5’CTGGATCATTTTCCGATG-3’ 
LITSRR (REV) 5’AGAGTGAGGGCGCGGATA-3’ 
 
GP63 
 
 
Gp63-1 5’-TCCACCGAGGACCTCACCGA-
3’ 
Gp63-2 5’-GTCGTACCGCGACGCAATGT-
3’ 
Gp63-3 5-ACATTGCGTCGCGGTACGAC-3’ 
Gp63-4 5’-GTAGAAGCCGAGGTCCTGGA-
3’ 
Gp63-5 5’TCCAGGACCTCGGCTTCTAC-3 
Gp63-6 5’CTGGCACACCTCCACGTACG-3’ 
Gp63-7 5’AGAGTGAGGGCGCGGATA-3’ 
 
 
 
 
 
 
 
 
 
 
CHAPTER THREE 
 
RESULTS 
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RESULTS 
 
3.1  Parasite Culture Results 
Parasite culture was succeeded in five out of the eight cutaneous samples. 
 
3.2  Real Time PCR Results 
Overall, the diagnosis of leishmaniasis was confirmed by real time PCR in 40 patients out of 
72 (55.6%). The real time PCR confirmed 58 samples out of 111 (52.3%) as Leishmania positive. 
The positivity in real time PCR was higher for HLN samples (66%) compared to HBM (57%) and 
HB (29%). 
 
3.3  kDNA Results 
kDNA PCR Results 
The PCRs targeting the kDNA produced the expected amplificates ( Figure 10) in nearly 
90% of the real time PCR positive samples, only few blood samples gave negative results. 
 
 
Figure 10: four amplificates obtained by the primers AJS3/R1 to the left of the molecular ruler and 
primers F2/DBY to the right of the molecular ruler. Amplificates were loaded in acrylamide gel and stained 
by silver staining. Positive control occupy positions N° 1 and 6, molecular ruler position N° 5. 
 
kDNA Sequences Results 
Although the gel showed an assertive band for each PCR product, kDNA sequences of CL 
samples (samples 108, 109 110 and 111) attributed to cutaneous cultures gave doubtful results, and 
were different from the other cutaneous samples (sample 107 and 111) (Figure 11). On the other 
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hand Sequences analysis of bone marrow samples (HBM), blood and Lymph node showed very 
different and unexpected results (Figure12) and as kDNA is not a single copy gene, it has been 
forsaken and used for confirmation purposes only. 
 
Figure 11:  schematic demonstration of kDNA sequences obtained by direct sequencing of four CL isolates 
(samples number 108, 109, 110 and 111) showing an example of nucleotide’s overlapping  in positions 633, 
687 and 692, (position according to L.donovani GenBank
TM
 accession number AF103737). 
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Figure 12: schematic demonstration of kDNA sequences obtained by direct sequencing of ten HBM isolates and 
L.infantum reference strain  used in this study. 
 
3.4 Cytochrome Oxidase II gene Results 
COII PCR Results  
The PCR targeting the COII gene produced the expected amplificates ( Figure 13) in all the 
real time PCR positive samples. 
 
 
Figure 13: showing thirteen amplificates obtained by the primers COII F and COII 
R. The positive control L.infantum is the last to the right. Amplificates were loaded 
in acrylamide gel and stained by silver staining. Molecular ruler in position N° 7. 
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COII Direct Sequence Analysis Results 
All samples associated with VL (except 14HBM), PKDL and ML clinical forms, together 
with two samples associated with CL cultures (samples 107 and 111) showed a unique sequence 
pattern and gave 100% genetic homology to L. donovani AY660023.1 reference sequences 
deposited in GenBankTM (Figure14 and Figure 15). Three CL sequences showed overlapping 
nucleotides peaks and these sequences were compared to L.major MON 25 and to our above 
mentioned sequences (Figure 16). 
 
 
  
 
Figure 14:  Phylogenetic tree of COII sequences. Phylogenetic tree based on a fragment of 600 bp of COII gene 
of  Leishmania parasite. Sequence dataset was analyzed using MEGA 5, the neighbour-joining (NJ) method, and 
bootstrap analysis (1,000 replicates) based on the ClustalW algorithm. Significant bootstrapping values (>70%) 
are shown on the nodes. Only representative sequences were shown. 
Number indicates the sample number, HBM indicates Human Blood Marrow origin sequence, HLN  indicates 
lymph node origin sequence and HB indicates Human Blood origin sequence used in this study. ( )sequences  
number 107 and 111originated from skin culture amplificates and associated with CL patients,  ( )  Leishmania 
GenBank
TM
 reference sequence (L.donovani GenBank
TM
 accession number AY660023; L.major GenBank
TM
 
accession number AF63316; ( ) L.major MON 25  and our positive control L.infantum MHOM/TN/80/IPT1  used in 
this study. 
 
 
 
52 
 
 
 
 
 
 
COII Cloning Results 
 
 
Figure15 : Genetic differences of nine COII sequences. Genetic differences  based on a  600 bp fragment of 
the COII gene of Leishmania parasite. Sequence dataset was analyzed using MEGA 5. Leishmania 
GenBank
TM
 reference sequence  used here are L.donovani GenBank
 TM
 accession number AY660023; 
L.major GenBank
 TM
 accession number EF633106; and our positive control L.infantum 
MHOM/TN/80/IPT1. 
 
 
 
Figure 16: schematic demonstration of COII sequence obtained by direct sequencing of one CL isolate (sample 
number 109) showing overlapping of  nucleotides in position 93,99, 153 159, 162 and 173 (position according 
to L.donovani GenBank
TM
 accession number AY660023), CL sequence compared to  L.major MON 25 and to 
our 3HBM sequence that gave 100% identity to L.donovani (GenBank
 TM
 accession number AY660023). 
53 
 
Thirty-four, twenty nine and thirty six sequences were obtained from cloning of CL samples 
number 108, 109 and 110, respectively. Sequence data from colonies were assembled and edited 
with SeqScape software v2.5 and analyzed in MEGA 5 software as mentioned previously. Two 
different sequence patterns have been revealed corresponding to L. donovani with genetic similarity 
range between 99.5%-100% to L. donovani AY660023 GenBankTM reference sequence and to L. 
major with genetic similarity ranging between 98.9-99.3% % to L. major EF633106 GenBankTM 
reference sequence. The genetic similarity between the two GenBankTM reference sequences used 
here was 89.4%. (Figure17. and Figure 18) 
 
  
 
Figure 17: Phylogenetic tree of COII cloning  sequences. Phylogenetic tree based on a fragment of 600bp of 
COII gene of Leishmania parasite. Sequence dataset was analyzed using MEGA 5, the neighbour-joining (NJ) 
method, and bootstrap analysis (1,000 replicates) based on the ClustalW algorithm. Significant bootstrapping 
values (>70%) are shown on the nodes. Only representative sequences from each cloned sample were used, 
the same structure coloured icon indicates sequences from the same patient. ( )  Leishmania GenBankTM 
reference sequence (L.donovani GenBank TM accession number AY660023; L.major GenBank TM accession 
number EF633106; L.mexicana GenBankTM accession number HQ586845.1 and our positive control 
L.infantum MHOM/TN/80/IPT1. 
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Figure 18: Genetic differences of  the three COII cloned  sequences. Genetic differences  based on a  600 bp fragment of 
the COII gene of Leishmania parasite. Sequence dataset was analyzed using MEGA 5.only representative sequences from 
each cloned sample were included. the Leishmania GenBank
TM
 reference sequence  used here are L.donovani GenBank
 
TM
 accession number AY660023; L.major GenBank
 TM
 accession number EF633106; and our positive control L.infantum 
MHOM/TN/80/IPT1. 
 
3.5  Internal transcribed Spacer (ITS) Results 
PCR Results 
The PCR targeting the ITS gene produced the expected amplificates ( Figure19) . Ten 
samples were subjected to cloning. 
 
 
 
Figure 19: showing ITS amplificates obtained by the primers LITSR and LITSRR.. Amplificates were loaded 
in acrylamide gel and stained by silver staining. positive control in position N°1 and molecular ruler in the 
last  position  
Samples cloned and sequences obtained from colonies are shown in Table 5 
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Sample  
Identification 
Clinical 
 Manifestation 
N° of successfully  
sequenced  
colonies 
Length of sequences pb 
3HBM VL 26 930 
14HBM VL 27 830  
17HBM VL 27 843 
105  PKDL 38 845 
106 ML 45 845 
107 CL 40 836  
108 CL 23 900 
109 CL 13 900 
110 CL 14 751 
111 CL 38 850 
 
Table 5: Types and number of colonies obtained from each ITS cloned sample 
 
 
 
ITS Cloning Results 
Polymorphism of the sequences obtained from colonies is based on different microsatellite 
repeat numbers. We compared our polymorphic sites to those identified by Kuhls et al 2005, 
(Figure 20) who analyzed the ITS sequences of L.donovani complex members including 27 L. 
infantum, 2 L. chagasi, 18 L. donovani and 5 L. archibaldi strains of different zymodemes and 
geographical origin (Kuhls et al 2005). Our sequences lies between nucleotides position number 61 
and 937 in figure (17) .we have identified two other loci after poly (G2) named poly “CT” and poly 
“GT…. Poly TA”. 
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Figure 20: ITS sequence types found for strains of L.donovani complex (Kuhls et al 2005) 
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ITS 3HBM  
Thirteen colonies of the 3 HBM sample were studied. Five sequences were found to be type 
E, one type  F and five sequences type D (Figure 21). One sequence possessed mixed type E/F (at 
poly TA type E while at poly A type F), another sequence was found to be mixed type D/F( at poly 
TA type D while at the other polymorphic sites type F). In addition one modified type E sequence 
possess 8 G at poly G2 instead of seven . (Figure 21) No polymorphism was detected at sites poly G1  
 
 
Figure 21: 3HBM ITS polymorphic sites among 930 nucleotides 
 
Type Poly TA    Poly A 
 
Poly AT  poly TA Poly G2 
 
Poly GT…. Poly TA 
E TGTATATATATATATGTA 
 
GTAAAAAAAAGG GTATATATATAATT 
 
TGGGGGGGAGG 
 
TTGTGTGTGTGTGTATGT 
CACATATATATATCC 
 
Modified E TGTATATATATATATGTA 
 
GTAAAAAAAAGG 
 
GTATATATATAATT TGGGGGGGGAGG 
 
TTGTGTGTGTGTGTATGT 
CACATATATATATCC 
 
F TGTATATATATA--  TGTA 
 
GTAAAAAAA—GG 
 
GTATATATATAATT 
 
TGGGGGGGAGG 
 
TTGTGTGTGTGTGTATGT 
CACATATATATATCC 
 
Mixed 
E/F 
TGTATATATATATATGTA GTAAAAAAA—GG GTATATATATAATT 
 
TGGGGGGGAGG 
 
TTGTGTGTGTGTGTATGT 
CACATATATATATCC 
 
D TGTATATATA--  TGTA 
 
  GTAAAAAAA—GG 
 
GTATATATAATT TGGGGGGAGG 
 
TTGTGTGTGTGTATGT 
CACATATATATCC 
 
Mixed D/ F 
 
TGTATATATA--  TGTA 
 
GTAAAAAAA—GG 
 
GTATATATATAATT TGGGGGGGAGG 
 
TTGTGTGTGTGTGTATGT 
CACATATATATATCC 
 
 
ITS 14HBM 
Twenty colonies of the 14 HBM sample were studied. Four polymorphic sites similar to 
those of the Kuhls et al (2005) (Figure 22) were found, these sites are: poly TA, poly A, poly “AT + 
TA”, in addition to other two new polymorphic sites which have not been identified before. The 
first site is poly CT which consist of 4, 5 or 6 repeats of CT, this site lies between poly “G2 and poly 
TGG”, in our aligned sequences of the 14 HBM it took position from 824 to 837. The second site is 
the poly AT which consist of 4 or 5 repeats of AT at position from 843 to 852 in our 14 HBM 
aligned sequences. 
Type F is the dominant type, but it get modifications at some sequences, as example, two sequences 
of this type had 9 and 8 G at poly G2, another sequence is type F sequence but at poly G2 possess 
6G which are characteristic of types A, B, C, D. Another type F sequence at poly A and Poly “AT  
poly TA” possessed types A, B, C or D at poly TA . mixed F/ “Cor D” sequence was found (type F 
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sequence that possess type C or D at “Poly AT  poly TA”). Four sequences possessed mixed E/F 
type, at the poly TA, poly A they follow type E, while at Poly “AT  poly TA” they follow type F 
and they showed no polymorphism at the other sites. 
 
Type Poly TA    Poly A Poly AT  poly TA Poly G2 
 
Poly CT new 
 
Poly AT new 
 
Mixed E /F TGTATATATATATATGTA GTAAAAAAAAGG 
 
ACATATATATATTATACC(--) 
GTATATATATAATT 
TGGGGGGGAGG GCTCTCTCTCTGT  GGTATATATATGT seq N° 39 
 GGTATATATATAT--GT 
F TGTATATATATA..TGTA 
 
GTAAAAAAA-GG 
 
ACATATATATATTATACC(--) 
GTATATATATAATT 
TGGGGGGGAGG GCTCTCTCTCTGT 
 
GGTATATATATGT seq N°35 
GGTATATATATAT--GT 
MixedF/E 
 
TGTATATATATA..TGTA 
 
GTAAAAAAAA-GG ACATATATA—TTATA 
GTATATATATAATT 
TGGGGGGGAGG GCTCTCTCTCTGT GGTATATATATAT--GT 
Mixed F/ C or D TGTATATATATA..TGTA GTAAAAAAA-GG 
 
ACATATATATATTATACC(--) 
GTATATATAATT 
TGGGGGGGAGG GCTCTCTCTCTGT GGTATATATATAT--GT 
ABCD TGTATATATAT--  GTA 
 
GTAAAAAAA-GG ACATATATATATTATACC(--) 
GTATATATATAATT 
TGGGGGGGAGG GCTCTCTCT----GT 
 
GGTATATATATAT--GT 
Seq N° 2 TGTATATATATA..TGTA GTAAAAAAA-GG ACATATATATATTATACC(--) 
GTATATATATAATT 
TGGGGGGGAGG GCTCTCTCTCTCTGT GGTATATATATAT--GT 
Seq N° 45 TGTATATATATA..TGTA GTAAAAAA-GG ACATATATATATTATACC(--) 
GTATATATATAATT 
TGGGGGGGAGG GCTCTCTCTCTGT GGTATATATATAT--GT 
Seq N° 54 51 TGTATATATATA..TGTA 
 
GTAAAAAAA-GG 
 
ACATATATATATTATACC(--) 
GTATATATATAATT 
 
TGGGGGGGGGAGG 
TGGGGGGGGAGG 
 
GCTCTCTCTCTGT GGTATATATATAT--GT 
Mixed F/ABCD TGTATATATATA..TGTA 
 
GTAAAAAAA-GG 
 
ACATATATATATTATACC(--) 
GTATATATATAATT 
 
TGGGGGG-AGG 
 
GCTCTCTCTCTGT GGTATATATATAT--GT 
 
Figure 22: 14 HBM ITS polymorphic sites among 854 nucleotides 
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ITS 17 HBM 
Twenty six colonies of the 17HBM sample were studied. The majority of the sequences 
were  type F. Only four sequences were found to be type  E. Two sequences possessed modified 
type F (at Poly “AT  + TA” possess type C or D and at poly  G2 possess 9 G instead of 7). Three 
sequences possessed mixed type F/E hence at poly TA, they possessed type F and in poly A type E. 
(Figure 23). No polymorphysim was found at site poly G1. 
 
Figure 23: 17 HBM polymorphic sites among 843 nucleotides 
Type Poly TA    Poly A 
 
Poly AT  poly TA Poly G2  
 
E TGTATATATATATATGTA GTAAAAAAAAGG ACATATATATATTATACC(...) TGGGGGGGAGG 
F 
 
TGTATATATATA--  TGTA 
 
GTAAAAAAA--GG 
 
ACATATATATATTATACC(...) 
 
TGGGGGGGAGG 
 
 
Modified 
F 
TGTATATATATA--  TGTA 
 
TGTATATATATA--  TGTA 
GTAAAAAAA--GG 
 
GTAAAAAAA--GG 
ACATATATAT--TATACC(..) 
 
ACATATATATATTATACC(...) 
 
TGGGGGGGAGG 
 
TGGGGGGGGGAGG 
 
Mixed 
F/E 
 
TGTATATATATA--  TGTA 
 
GTAAAAAAAAGG 
 
ACATATATATATTATACC(...) 
 
TGGGGGGGAGG 
 
 
105 PKDL 
Twenty nine colonies of the 105 PKDL sample were studied. Ten sequences were found to 
be type E, three type  F. One sequence possessed mixed types, at the poly TA and poly A it gives 
type E, while in poly G2  it becomes type C. Four sequences  possessed 8 G in poly G2 , two were 
found to be type E and two type F in both previous polymorphic sites. Modified type E was also 
found in 8 other sequences that possess 10 A in the polymorphic site A and in one sequence with 9 
A and 9 G  respectively at the polymorphic sites A and G2. Modified type F was found in two 
sequences with 10 and 9 A at the polymorphic sites A. (Figure 24) . No polymorphysim was found 
at sites Poly “AT  + TA” nor at poly G1. 
 
 
 
 
 
 
Figure 24: 105 PKDL polymorphic sites among 843 nucleotides. 
Type Poly TA    Poly A 
 
Poly G2  
 
E TGTATATATATATATGTA GTAAAAAAAAGG TGGGGGGGAGG 
F TGTATATATATA--  TGTA GTAAAAAAA--GG TGGGGGGGAGG 
 
Modified E/F 
TGTATATATATATATGTA 
TGTATATATATA--  TGTA 
GTAAAAAAAAA-GG     
GTAAAAAAAAAAGG 
TGGGGGGGGGAGG  
TGGGGGGGGAGG 
Mixed E/C TGTATATATATATATGTA GTAAAAAAAAGG TGGGGGGAGG 
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106 ML 
Forty colonies of the 106 ML sample were studied. The majority of the sequences were  type 
E . Two sequences were found to be type  F. One sequence possessed mixed type E and F ( at poly 
TA seemed type E and in poly A seemed type F) (Figure 25).  
For all sequences, no polymorphism was found at sites Poly “AT +TA”, poly G1 and  poly G2.   
(Figure 25)  
Figure 25 
 
Figure 25: 106ML polymorphic sites. 
Type Poly TA Poly A 
 
  
E 
 
TGTATATATATATATGTA 
 
GTAAAAAAAAGG 
 
  
F 
 
TGTATATATATA--  TGTA 
 
GTAAAAAAAGG 
 
  
Mixed 
E/F 
TGTATATATATATATGTA 
 
GTAAAAAAAGG 
 
  
 
The new identified polymorphic site “CT” showed different patterns with 4, 5 or 6 repeats, figure 26 explains 
Poly CT . 
 
 
Figure 26 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Six sequences belonging to type E, showed two different sequence patterns at position 63 (850 
nucleotide) (Figure 27).  
 
 
 
 
 
 
Figure 26: 106 ML, poly CT, position 816 of the 850 nucleotide: the three different 
patterns of nucleotides 
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Figure 27: 106 ML, position 63 of the 850 nucleotide: the three different patterns of 
nucleotides 
ITS 107 CL 
Thirty four colonies of the 107CL sample were studied. Type E is the dominant with 
eighteen sequences. Modified type E that contain 9 G and 8 G at poly G2 is found in ten and three  
sequences respectively. Type F was absent but mixed type E/F is found in three sequences (Figure 
28). At poly CT only one sequence possessed 6 CT repeats while all the other possessed 5 repeats, 
while at “Poly GT+TA”,  all sequences have 5 TA repeats with the exception of  two sequences with 4 
repeats (Figure 28). No polymorphism was detected at “Poly AT + TA” or poly G1 
Interestingly,  two sequences (both type E, but one sequence possess 9G at poly G2 instead of 7)  showed a 
unique pattern , their poly TA contains 7 repeats. Positions 60 and position 768 showed additional 
polymorphism (Figure 29) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 28: 107CL polymorphic sites,  among 836 pb nucleotides 
 
Type Poly TA    Poly A 
 
Poly G2  
 
Poly CT Poly GT…. Poly TA 
E  
TGTATATATATATATGTA 
 
GTAAAAAAAAGG 
 
TGGGGGGGAGG 
 
 
 
GGCTCTCTCTCT—GT 
 
TGGTATATATATATGT 
 
 
 
Modified 
E 
 
TGTATATATATATATGTA 
 
 
GTAAAAAAAAGG 
GTAAAAAAAAAGG 
 
TGGGGGGGAGG 
TGGGGGGGGGAGG 
TGGGGGGGGAGG 
 
 
GGCTCTCTCTCTCTGT 
GGCTCTCTCTCT—GT 
 
 
 
TGGTATATATATATGT 
TGGTATATATAT--GT 
 
 
 
Mixed 
E/F  
TGTATATATATA--  TGTA 
TGTATATATATATATGTA 
 
GTAAAAAAAA—GG  
GTAAAAAAA—GG 
 
TGGGGGGGAGG 
 
GGCTCTCTCTCT—GT 
 
TGGTATATATATATGT 
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Figure 29:107 CL polymorphic sites at position 60, and 768 respectively 
 
ITS 111 CL 
Thirty colonies of the 111CL sample were studied. Type E and type F were fairly divided 
between colonies. Two sequences were found to be of mixed types E/F with poly TA similar to type 
E and poly A similar to type E. Modified type F was detected in two sequences, one with 9 A at 
poly A and 9 G  at poly G2, and the other with 6 A at poly A. Also modified type E exists in four 
sequences, two with 9 A at poly A, while the other two with 9 G at poly G2. (Figure 30) No 
polymorphism was detected at site G1, CT (all sequences with 5 CT) or poly TA (all sequences with 
5 AT). 
 
 
 
Figure 30:  111 CL polymorphic sites,  among 848 pb nucleotides 
 
Type Poly TA Poly A 
 
Poly G2 
 
E TGTATATATATATATGTA 
 
GTAAAAAAAAGG 
 
TGGGGGGGAGG 
F 
 
TGTATATATATATGTA 
 
GTAAAAAAAGG 
 
TGGGGGGGAGG 
 
 
Modified E 
 
 
TGTATATATATATATGTA 
TGTATATATATATATGTA 
 
 
GTAAAAAAAAAGG 
GTAAAAAAAAGG 
 
TGGGGGGGAGG 
TGGGGGGGGGAGG 
 
Modified F TGTATATATATATGTA 
 
GTAAAAAAAAAGG 
GTAAAAAAGG 
TGGGGGGGGGGAGG 
TGGGGGGGAGG 
Mixed 
F/E 
TGTATATATATA--  TGTA GTAAAAAAAAGG TGGGGGGGAGG 
 
ITS 108 CL 
Twenty two colonies were studied. Two very distinct sequence patterns were detected. In 
BLAST homology analysis, one pattern corresponds to L. donovani and the other to L. major. 
(Figure 31) demonstrates the two sequence types. 
63 
 
 
 
Colonies of the L. major groups (21 colony) were alligned. Five polymorphic sites were 
detected. (Figure 29). One sequence related to L. donovani (108 15) was found to be modified 
type E. It has poly TA similar to type C or D ( i.e. contains 3 TA repeats instead of 4). 
Figure 32 
 
First site 
Poly TA 
Second site Third site 
Poly AT* 
Forth site** Fifth site*** 
TCTATATATATATAGT
(19) 
TCTATATATATA--GT
(2)
 
CTTTT-AT(
20)
  
CTTTTTAT(
1)
 
CATATATATATATATATATATGT(
2)
 
CATATATATATATATATA--TGT
(5)
 
CATATATATATATATA----TGT
(11)
 
 CATATATATATATA------TGT
(3)
 
AGAAGACA
(11)
 
AGA---CA 
(12)
 
GGTATATATATATATGT
(20)
 
1.GGTATATATATAT—GT
(1)
 
Figure 32: 108 CL polymorphic sites of L.major related colonies at positions 8, 54, 491, 712  and 864 respectively. 
Polymorphic sites were shown in bold letters and underlined dots. Number between brackets indicates the number 
of colonies with the same sequence. * indicates similar sites in  109 and 110 samples. 
 
 
 
 
 
 
 
 
 
 
 
Figure 31: showing partial seqment of the two sequence patterns optained from the cloning of 108 CL sample, the 
upper sequence is clony N° 15 L.donovani, the lower sequence is colony N° 4 correspond to L.major. 
64 
 
ITS 109 CL 
Thirteen colonies were studied, and as in 108, L. major and L. donovani sequence patterns 
were detected. Ten sequences correspond to L. major with two polymorphic sites (Figure 33)  
 
 
 
 
 
 
 
 
 
Figure 33: 109 CL polymorphic sites of L.major related colonies  . Polymorphic nucleotides were shown in 
bold letters and underlined dots. Number between brackets indicates the number of colonies with the same 
sequence. * indicates similar sites in  108 and 110 samples. 
 
 Poly AT* *** 
109 CATATATATATATATATATATGT(4)
 
CATATATATATATATATA--TGT
(6) 
GGTATATATATATATGT
(8) 
GGTATATATATA--TGT
(2) 
 
 
 
Two of the three remanining sequences (109-25 and 109-28)   were found to be modified type E 
and modified type F, respectively. The two sequences have poly TA similar to type C or D, i.e. 
contains 3 TA repeats instead of 4. The third sequence (109- 4)  seemed to be a hybrid strain 
between L. donovani and L. major, it contains two  genetic blocks, the first consist of 612 
nucleotides  identical to L. donovani, and the second block of 290 nucleotides identical to that of L. 
major (Figure34 and Figure 35) 
Figure 34 
Figure 34:  the structure of a hybrid sequence obtained from cloning of sample 109 
 
612 pb nucleotide 100% L.donovani CTTT TT CT CTTT 
 
290 pb nucleotides 100% L.major 
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Figure 35:  hybrid sequence found in one colony of the cutaneous sample (colony N° 4) compared to two 
sequence patterns from the same sample attributed to L.donovani (colony N° 25)   and to L.major (colony N° 
34). Dots indicate similar sequence to L.donovani and the highlighted part similar sequence to L.major.   
 
 
 
 
 
 
109_25 TGT ATA TAT ATA TAT GTA GGC CTT TCC CAC ATA CAC AGC AAA GTT TTG TAC TCA AAA TTT GCA GTA AAA AAA AGG CCG 
109_4  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... 
109_34 .A. ... ... .-- -G. A.. ... T.. ... ... ... ... ... ... C.. ..A ... ..G ... ... ... ... ... ..- -.. .. 
. 
109_25 ATC GAC GTT ATA --A CGC ACC GCC TAT ACA --A AAG CAA AAA TGT CCG TTT ATA CAA AAA A-T ATA CGG CGT TTC GGT 
109B_4  ... ... ... ... --. ... ... ... ... ... --. ... ... ... ... ... ... ... ... ... .-. ... ... ... ... ... 
109B_34 ... ... ... G.. GA. ... ... ... ... ... CA. ... ... ... ... ... ... ... ... ... .A. .G. ... ... ... ... 
 
109_25 TTT TGG CGG G-- --- --- --- -GT GGG TGC GTG TG- -TG GAT AAC GGC TCA CAT AAC GTG TCG CGA TGG ATG ACT TGG 
109_4  ... ... ... .-- --- --- --- -.. ... ... ... ..- -.. ... ... ... ... ... ... ... ... ... ... ... ... ... 
109_34 ... ... ... .AG GGA GAG AGA G.G ... ... ... C.C G.. ... ... ... ... ... ... ... ... ... ... ... ... ... 
 
109_25 CAC GCC GCC TCC TCT CTT CTG CAC ATA TAT ATA TTA TAC CAT ACA CAG TAT ATA TAT AAT TAT GTG TTG GAA GCC AAG 
109_4  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... 
109_34 ... ... ... ... ... ... ... ..T ... .T. ... .-- --- -.. .T. ..A ... ... -.. .-- ... ... .-. ... ... ... 
 
109_25  AGG AGG CGT GTG TTT GTG TTG TGC GCA TAT -TA TAT GTA TAT ATG C-T GTG TGC ACA CGT AGA CAA GTT AGA GTT GGA 
109_4  ... ... ... ... ... ... ... ... ... ... -.. ... ... ... ... .-. ... ... ... ... ... ... ... ... ... ... 
109_34 ... ... ... ... ... ... ... ... C.. ... A.. ... A.. ... ..A TG. ... ... ... ... ... ... ..C ... ... ... 
 
109_25 CAA ATA CAC ACA --- -TG CAC TCT CTT TTG TGT GGG CGC GCG CGT GGA AAC TCC TCT CTG GTG CTT GCA AAG CAG TCT 
109_4  ... ... ... ... --- -.. ... ... ... ... ... ... T.. ... ... ... ... ... ... ... ... ... ... ... ... ... 
109_34 ... ... ... ..G CGT G.. ... ... ... ... ... .C. T.. ... ... ... ... ... ... ... ... ... ... ..- -.A G.A 
 
109_25 TTT T-- CTC TTT CTC TTT --- --- --- --T TCT CTC TCC ATT CTC TCC TCT CTT TTT T-C ATC AAA AAG GGG GGA GAG 
109B_4  ... .-- ... ... ... C.. CTC CTT TCT CT. ... ... ... ... ... ... ... ... ... .T. ... ... ... ... ... ... 
109B_34 G.C .TT .C. ... ... C.. CTC CTT TCT CT. ... ... ... ... ... ... ... ... ... .T. ... ... ... ... ... ... 
 
109_25 AAA AAG AGA GAG GAG --- --- --- -GG GGT CG- --- AGG GAG AGA GGC TGT GAC CAG GAT TAT TAA ACA AAA AAC CAA 
109_4  ... ... ..G ... A.. AAG ACA CGC G.. A.. ..C GAG G.A ... ... ... ... ..T T.. ... ... ... G.. ... ... ... 
109_34 ... ... ..G ... A.. AAG ACA CGC G.. A.. ..C GAG G.A ... ... ... ... ..T T.. ... ... ... ... ... ... ... 
 
109_25 AAC GAG AAT TCA ACT TCG CGT TGG CCA TTT TTT GCT TAA TGG GGG GGA GGT GG- GTG TGG GTG GTG TGT GGC TCT CTC 
109_4  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... .TG ... ..T ... ..T ... ... GC. CT. ... ... 
109_34 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... .TG ... ..T ... ..T ... ... GC. CT. ... ... 
 
109_25 TCT --G TGT GGT ATA TAT ATA TGT ATA T-T AGA AGT AGG TTG --- --- --- --- --- --- --- --- --- --- --- 
109_4  .G. AT. ... ... ... ... ... .A. G.. .A. .T. T.. .TA .AT ATG TAT GTT AGA GGT AGG T-- --- --- --- --- 
109_34 .G. AT. ... ... ... ... ... .A. G.. .A. .T. T.. .TA .AT ATG TAT GTT AGA GGT AGG TGT GTG TGT --- --- 
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ITS 110 CL 
Fourteen colonies were studied, one sequence corresponds to L. donovani and thirteen to L. 
major. Three polymorphic sites of the L. major group were detected.  
Figure 36 
 
 
 
 
 
 
Figure 36: 110CL polymorphic sitesof L.major related colonies. Polymorphic sites were shown in bold 
letters and underlined dots. Number between brackets indicates the number of colonies with the same 
sequence. * indicates similar sites in  108 and 109 samples 
  
Poly AT* 
 
** 
 
PolyA1   Poly A2 
110 
 
CATATATATATATATATATGT 
(5) 
CATATATATATATATAT—GT
(7)
 
CATATATATATATAT----GT
(1)
 
AGAAGACA
(7)
 
AGA---CA
(6)
 
ACAAAAAAAACCAAAAACG
(1)
 
ACAAAAAAA-CCAAAAACG
(1)
 
ACAAAAAAA-CCAAAA--CG
(2)
 
ACAAAAAA--CCAAAA-CG
(9)
 
The sequence related to L. donovani (110-2) was found to be modified type E. It has poly TA 
similar to type C or D ( i.e., contains 3 TA repeats instead of 4). 
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Phylogeny of Cutaneous Samples  
The phylogenetic analysis of the ITS cloning sequences  (samples108, 109 and 110) 
revealed two different sequence patterns, corresponding to L. donovani with 99.5-100% genetic 
similarity to L. donovani AJ634357 GenBankTM reference sequences and  99.8-100% to L. major 
FJ753391 GenBankTM reference sequences. The genetic similarity between L. major and L. 
donovani used in this study was 93.5%  (Figure 37). 
 
 ITS 110 40
 ITS 109 15
 ITS 110 37
 ITS 110 39
 ITS 109 18
 L.major
 ITS 108 33
 ITS 109 4
 ITS 108 15
 ITS 109B 28
 L.donovani
 ITS 110 2
 ITS 109 2570
96
100
0.005  
Figure 37:  Phylogenetic tree of ITS cloning  sequence of cutaneous samples. Phylogenetic tree (unrouted) based on a 
fragment of  970 bp of ITS gene of Leishmania parasite. Sequence dataset was analyzed using MEGA 5, the neighbour-
joining (NJ) method, and bootstrap analysis (1,000 replicates) based on the ClustalW algorithm. Significant 
bootstrapping values (>70%) are shown on the nodes. Only representative sequences from each cloned sample were 
used, the same structure cloured icon indicates sequences from the same patient. ( )  Leishmania GenBankTM reference 
sequence (L.donovani GenBankTM accession number AJ634357; L.major GenBankTM accession number FJ75339 
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3.6 GP63 Results 
PCR Results 
The PCRs targeting the Gp63 produced the expected amplificates (Figure 39) in all tested 
samples. 
               
Figure 38:  showing some of the amplificates obtained by the primers gp63 1/2 to the left 
and primers gp63 3/4 to the right. Amplificates were loaded in acrylamide gel and stained by silver 
staining. Positive control in position N° 1 and the molecular ruler in position N° 7 in both gels. 
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GP63 Sequence Results 
Seventeen sequences were found to possess multi nucleotidic superposition (from position 
810 to position 895 on the gp63 nucleotidic sequence, positions given according to the GenBank 
gp63 sequence accession number  GQ301544) (Figure 40). 
 
 
 
 
 
 
 
 
Figure 39: schematic demonstration of gp63 3/4 sequences obtained by direct sequencing of some VL isolates  showing an 
example of nucleotide’s  
overlapping from position 810 to position 895 on the gp63 nucleotidic sequence, positions given according to the GenBankTM 
gp63 sequence  
accession number  GQ301544). 
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GP63 cloning Results 
A total of 149 sequences were successfully obtained from colonies of the DNA from the six 
patients. The number of the sequence patterns obtained from each patient is shown in Table 7 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 7: number of the sequence patterns obtained from each patient 
 patient code N° of sequences 
from cloning 
Patient 1 3HBM 28 
Patient 2 7HBM 19 
Patient 3 10HBM 12 
Patient 4 11HBM 29 
Patient 5 14 HBM 26 
Patient 6 17 HBM 35 
 
GP63 Analysis 
As, we aligned our sequences with those of the gp63 
SHORT
 (Mauricio et al, 2007). Mauricio 
et al (2007) have determined the two groups of the GP63, i.e the gp63 
SHORT
 and the gp63 
EXT
 of the 
Old World Leishmania, using thirty-three strains of the L. donovani complex of diverse origins and 
zymodemes, thirty seven reference strains of other OW Leishmania and published sequences for 
gp63
EXT
 of L. major and L. mexicana). Our GP63 sequences belonged to six different clusters, one 
cluster associated with L. infantum genetic group while three clusters associated with L. donovani 
genetic groups. The remaining two clusters (group 1 and group 2) remains within the L. donovani 
complex, but differ from both L.donovani and L.infantum (Figure 40). The GP63 between group 
mean distance is shown in Table 8  
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 14HBM-2
 7HBM-4
 gb|U48798.1 L.infantum
 gb|M80669.1 L. donovani chagasi
 7HBM-16
 10HBM-32
 7HBM-3
 gb|M60048.1 L.donovani
 7HBM-1
 3HBM-10
 3HBM-4
 11HBM-1
 3HBM-19
 11HBM-25
Group 1
 7HBM-7
 7HBM-9
 14HBM-13
 gb|L19562.1 L.donovani
 14HBM-24
 10HBM-1
 10HBM-21
Group2
 gb|L19563.1 L.donovani
 14HBM-1
 14HBM-16
 14HBM-22
 Y00647.1| L. major
 gb|M94365.1| Crithidia fasciculata
98
93
99
76
98
78
100
85
89
86
83
71
70
97
74
99
0.1  
Figure 40: Phylogenetic analysis of the  sequences obtained from cloning of five samples from five VL patients  and 
the gp63
 SHORT
 (Mauricio et al 2007) published sequences. The same colour indicates sequences obtained from the 
same patient.  Phylogenetic tree based on a fragment of 370 bp of gp63 
SHORT
 gene of Leishmania parasite. Sequence 
dataset was analyzed using MEGA 5, the neighbour-joining (NJ) method, and bootstrap analysis (1,000 replicates) 
based on the ClustalW algorithm. Significant bootstrapping values (>70%) are shown on the nodes. 
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Table 8: gp63 between groups mean distance 
gp63 
SHORT
 groups 1 2 3 4 5 6 
1.L.infantum cluster       
2.L.donovani M60048 cluster 3.6      
3.L.donovani 19562.1 cluster 12.7 11.1     
4.L.donovani 19563.1 cluster 14.0 13.4 14.5    
5.Group1 7.2 4.3 7.7 13.2   
6.Group2 14.1 14.3 18.5 19.1 14.2  
 
 
 
3.7 MSPC Results 
Twenty nine and nineteen sequences were obtained from the colonies of the 14 HBM and 
11HBM samples, respectively. Sequences were aligned with the the GP63
 EXT
 published sequences 
(Mauricio et al, 2007) (Figure 41 and Figure 42). 
All 14 HBM sequences were clustered into one group, GP63 
EXT 
MON 31and MON 83 
(Mauricio et al, 2007). The within group mean distance is 0.9 for both, and all 11 HBM sequences 
18 30 
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 14HBM GP63 mspC 16
 14HBM mspC 2
 14HBM GP63 mspC 3
 14HBM GP63 mspC 10
 14HBM GP63 mspC 1
 14HBM GP63 mspC 29
 14HBM GP63 mspC14
 14HBM GP63 mspC 13
 HUSSEN_MON_31_GROUP_E
 14HBM GP63 mspC 17
 14HBM GP63 mspC 8
 ADDIS_164_MON_83_GROUP_E
 14HBM GP63mspC 28
 14HBM GP63 mspC 4
 WangJie1_MON_35_GROUP_F
 BUCK_MON78
 IPT1_MON_1
 Bumm3_MON_43_GROUP_G
 Marz-Krim_MON_73_GROUP_H
 Sukkar2_MON_3_GROUP_F
 GILANI_MON_30
 HU3_MON_18
 DD8_MON_2_GROUP_B
 MUTINGA_H9_MON_32_GROUP_A
 MRC(L)3_MON_37_GROUP_A
 MRC74_MON_2_GROUP_A
 LRC_L57_MON_37_GROUP_A
 NDANDU_4A_MON_44_GROUP_A
 AYELE_8_MON_56_GROUP_A
 Neal-R1_MON_56_GROUP_A
 L.aethiopica___MON_14
 L.tropica__MON_60
 gb|AF039721.1|_L._major
 L.arabica__MON_64
 L.turanica_MON_81
 emb|X64394.1|_L.mexicana
99
98
94
99
95
79
75
79
80
69
100
100
99
98
100
92
0.02  
Figure 41: Phylogenetic analysis of the sequences obtained from cloning of sample 14 HBM and the gp63
 EXT 
published sequences (Mauricio et al 2007).  MON Zymodemes are shown., gp63 ext groups are shown in letters 
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from A-H. Phylogenetic tree based on a fragment of 1044 bp of gp63 gene of Leishmania parasite. Sequence dataset 
was analyzed using MEGA 5, the neighbour-joining (NJ) method, and bootstrap analysis (1,000 replicates) based on 
the ClustalW algorithm. Significant bootstrapping values (>70%) are shown on the nodes. 
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Figure 42: Phylogenetic analysis of the sequences obtained from cloning of sample 11 HBM and the gp63
 EXT 
published sequences (Mauricio et al 2007).  MON Zymodemes are shown., gp63 ext groups are shown in letters 
from A-H. Phylogenetic tree based on a fragment of 1044 bp of gp63 gene of Leishmania parasite. Sequence 
dataset was analyzed using MEGA 5, the neighbour-joining (NJ) method, and bootstrap analysis (1,000replicates) 
based on the ClustalW algorithm. Significant bootstrapping values (>70%) are shown on the nodes. 
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DISCUSSION 
 
This chapter will summarize findings of this study and will discuss issues raised as the 
presence of mixed infection, the frequency and the transmission route in nature of such infections, 
the role of the culture media and other selection pressures in Leishmaniasis and the robustness of 
the present taxonomy. 
 In the present study, five CL samples from five patients have been examined, three of them have 
been cloned for COII and ITS genes. The five patients were presented with typical localized 
cutaneous ulcers with neither evident signs of systemic illness or immunosuppression nor VL. All 
patients originated from a VL non-endemic areas and had no history of travelling to a known VL 
endemic area. However, even if visceral involvement or immunosuppression were not clinically 
suspected, no other clinical or laboratory examinations were carried out.  
COII and ITS analysis of two CL samples (107CL and 111CL) confirmed L. donovani as the 
merely etiological agent, findings concordant with other’s results (El Amin et al., 2004). moreover, 
the ITS analysis showed that at least two different strains / hybrids of L. donovani co-exist within 
the same patient..  
ITS sequence data of these samples (107CL and 111CL) showed different ITS results 
The 107 sample which has been extracted after being mass cultured, showed dominant L. donovani 
type E and absence of  type F ( type E is characteristic of L. infantum, MON 30, MON81 and L. 
archibaldi MON 82, while type F is characteristic of L. infantum MON 30 and MON 267 and L. 
donovani MON 18 according to Kuhls et al 2005 characetrization). GG and GGG insertions were 
intensively present at poly G2 and some sequences showed a unique poly TA pattern.  
Regarding Sample 111CL that has been extracted at the primary phase of culture, both type E and 
type F were fairly presented among colonies. Also GGG insertion at poly G2 was detected. 
Polymorphisms at poly A witnessed both insertions and deletions of A in some uncharacterized 
sequences. We can conclude that the ITS sequence data support the presence of more than one 
strain of L. donovani in some CL patients. 
We also assessed the presence of mixed infection with two Leishmania species from a single 
cutaneous aspirate in the other three CL patients (samples 108, 109 and 110). The COII and the ITS 
genes analysis gave concordant results and confirmed -for the first time- naturally mixed infection 
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with L. major and L. donovani. (Figure 17 and Figure 38). The ITS sequence data analysis of L. 
major related colonies in the three CL samples revealed the presence of more than one strain 
/hybrid of L. major as different polymorphic sites were detected within and between patients (five 
polymorphic sites in  108, two in 109 and three in 110 samples) (Figures 32, 33 and 36). Only few 
L. donovani related colonies were detected possessing polymorphic sites belonging in some sites to 
type E, while in other sites to type D or C (type D is characteristic of L. archibaldi MON 82, MON 
258, MON 257, L. donovani MON 274 while type C is characteristic of L. donovani MON 35).  
Most interestingly, one hybrid strain containing L. donovani sequence at the initial part and 
L. major at the last part was detected in one CL patient (sample 109 Figure 34).  
L. infantum similar COII sequence has been found in one VL sample (14 HBM), regarding 
the same sample, the GP63 sequence data analysis confirmed some colonies as L. infantum (Figure 
40). At the same time, two out of the six identified polymorphic sites (poly G2 and poly TA) in the 
ITS were similar to those of types A, B, (types A and B were characteristic for L. infantum different 
zymodems) (Figure 22). On the other hand, the MSPC gene put this sample (14HBM) within one 
group belonging to L. donovani MON 31 and MON 83. As the 14HBM, another VL sample, namely 
7HBM, shared some colonies with L. infantum genetic group in the GP63 (Figure 40). 
Although COII gene analysis identified  L. donovani as the merely causative agent of the  
PKDL  (sample 105) and  ML (sample 106)  the number of samples from these forms was not 
sufficient to draw a conclusion., However, ITS data analysis pointed type E as the dominant type in 
both samples, but  considerable different sequence patterns were detected between colonies from 
the two samples, poly G2 in sample 105 witnessed insertion of G,GG and deletion of G while 
positions 63 and 850 witnessed insertions of AT, A  in the first sample and TCT, T and C at the 
second sample (Figure 26 ) 
For other two samples (3HBM and 17HBM) attributed to VL identified by the COII gene as 
L. donovani, ITS data pointed in the first sample types E and D as the dominant types, while in the 
second sample type F. Insertion of G at poly G2 was present in both samples (Figures 21, 23). 
Two genetic groups, both within the L. donovani complex but different from L. infantum and 
L. donovani in the Gp63 sequence data analysis of some colonies attributed to VL samples (namely 
10 HBM, 3HBM and 11HBM) have been identified (Figure 40). In the MSPC gene, sample 11 
HBM colonies clustered within L. donovani  MON 30 and MON 18 (Figure 42) 
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It has been generally accepted that Leishmaniasis in Sudan is caused by L. major  and by the 
members of L. donovani complex, even if the presence of L. infantum has been denied by some 
authors (Jamjoom et al., 2004). No other species were reported. L. major and L. donovani have 
different transmission vectors and distinct biologic properties and epidemiologic features, both have 
been reported as etiologic agents of CL in Sudan. CL due to L. major LON1 is transmitted by P. 
papatasi in arid and semi-arid areas and circulates among rodents (el-Hassan& Zijlstra, 2001), 
while the vector that transmit CL due to L. donovani has not been established yet. On the other 
hand, Sudanese L. donovani  complex are considered to be genetically homogenous group 
regardless the wide differences in clinical manifestations. 
Co-infection with different Leishmania has been reported in closely related Leishmania species 
such as L. braziliensis and L. panamensis (Belli et al., 1994)  and L. major and L. arabica (Shirian 
et al., 2012). The only two reports on concomitant natural infection with L. donovani and L. major 
were reported in Iraq where the two species were isolated from two different sites, the bone marrow 
and cutaneous lesions of a Kala azar suffering patients (Al-Diwany J. et al; 1995) and in Kenya 
where isolation succeeded from spleen aspirate culture from a clinically relapsed Kala azar 
suffering patient (Mebrahtu et al., 1991). Concomitant infection with divergent Leishmania species 
has also been reported. The two species L. infantum and L. major have been isolated from the 
spleen of VL/HIV immune-compromised patient (Ravel et al., 2006). 
Most laboratories in practice rely on culture for Leishmania isolation, diagnosis and DNA 
extraction for genetic typing. However, it has been demonstrated that in culture some strains 
overgrow and tend to eliminate other strains (Ibrahim et al., 1994). Previous studies carried out on 
the gp63 gene in Sudanese patients from the same area resulted on genetic homogeneity of the 
Leishmania isolates (PhD thesis, Khartoum University, unpublished data). Differently, in our study 
DNA was extracted directly from biological material, likely maintaining intact the different strains 
composition of the samples. The selection of a single strain in culture, if corroborated by other 
evidences, could also make necessary to reconsider the association of Leishmania species with 
clinical manifestations, such as L.  donovani causing CL (Elamin et al, 2008) or L.infantum and 
PKDL (Dereure et al, 2003) 
In the present study, the two species were likely maintained because the cultured parasites 
were harvested and extracted during early growth at the third day of culture. However, after 
cloning, the number of colonies related to L. major genetic group was higher compared to that 
related to L. donovani genetic group in both COII and ITS genes. This may suggest the dominance 
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of L. major species in the co-culture; however, it is also possible that the PCR conditions were more 
efficient towards L. major genome. 
The occurrence and frequency of natural infection with more than one Leishmania, 
especially   where foci of two species overlap, is believed to be more prevalent than reported and it 
has been demonstrated that in co-cultivation of more than one Leishmania, the dominant species 
tend to inhibit the growth of the other; as a consequence, the degree of laboratory detection of such 
phenomenon remains unclear and likely underestimated (Pacheco et al., 1987; Ibrahim et al; 1994). 
The transmission route of naturally mixed infection remains debated. However, the presence 
of genetically different populations of P. papatasi in Sudan has been recently reported ( Khalid NM 
et al., 2012). Moreover, high polymorphism has been attributed to L. major causing cutaneous 
diseases in Iran (Oryan A et al., 2013). 
P. papatasi is not a vector of visceral leishmaniasis and is refractory to the infection by L. 
infantum and L. donovani  (Pimenta et al., 1994; Myskova et al; 2007). However, an experimental 
evidence of P. papatasi infection with hybrid strains of L. infantum/L. major causing visceral 
disease in HIV-positive patients (Volf et al., 2007) has been documented.  Based on these results P. 
papatasi has been suggested as vector of this hybrid in nature (Volf et al., 2007). 
 In our study several different strains of L. donovani and of L.major were simultaneously 
found within the same patient and for most of them it was not possible the identification at the 
species level. This in one hand confirms that some genes can provide the basis for genotyping of 
strains within the L. donovani complex, but also highlights the internationally recognized need for a 
revision of the taxonomic status of Leishmania species (Schonian et al., 2010; Van der Auwera et 
al., 2011; Boitè et al., 2012; Almeida and Araujo, 2012 ). 
High percentage of VL Sudanese patients develop PKDL shortly after treatment. However, 
the responsibility of some strains to the subsequent onset of PKDL or other clinical manifestations 
remains an open question and need further insights. 
GP63 
SHORT
 and MSPC (also known as Gp63
EXT
) are the two classes of the GP63 gene 
family in the subgenus L. (Leishmania) (Medina-Acosta et al., 1993). In the L. infantum genome, 
four identical copies of the GP63
SHORT 
were identified while the MSPC seems to be single copy 
gene (Ramamoorthy et al., 1992). In the present study, the GP63 
SHORT  
phylogenetic analysis of the 
14 HBM samples gave different sequence patterns grouped into three main groups, while the MSPC 
analysis gave only one group. This could be explained by either that the 14HBM sample contains  
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more than one genome with much similar MSPC sequence or that the same genome contained 
non identical GP63SHORT copies, even though  finding of other genes supported the hypothesis that 
this sample could contain more than one genome, at least one of them contain non identical 
copies. 
Biomolecular Discussion 
The modified real time PCR used in this study revealed to be a useful tool for the screening 
of a large number of samples. The Cytochrome Oxidase gene used in this study for differentiating 
the positive isolates at  species level and it was not able to reveal the intraspecific polymorphism. 
While the GP63  SHORT and the ITS genes are suitable genes for intraspecific polymorphism and 
strains detection. The MSPC gene  showed gene conservation in the  two tesed VL samples. 
However, the data obtained from the kDNA gene that has been abondonated seemed to supports 
finding of this study, even if no cloning technique was done 
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CONCLUSION 
 
This study attempted to understand the correlation between different clinical manifestations and 
the genetic profile of Leishmania positive isolates from Sudanese patients diagnosed with different 
types of leishmaniasis using the  COII, the ITS and the GP63 (gp63 3-4 and MSPC) genes as targets 
for characterization and identification of intraspecific polymorphisms using direct sequencing and 
cloning techniques. From the results we can in summary conclude:  
The study affirmed the presence of mixed infection with L. donovani and L. major  from a 
single cutaneous aspirate in CL patients. To the best of our knowledge this is the first report 
of L. donovani and L. major mixed-infection in Sudan. Additionally no other cases of such 
mixed-infection from the same cutaneous sample were reported elsewhere. 
The study assessed the circulation of more than one strain/hybrid of L. major and L. donovani 
between Sudanese patients. 
The presence of L. infantum as an etiological agent of VL in Sudan was confirmed by CO II 
and ITS genes. 
Leishmania isolates with mixed species or strains might be subjected to selective pressure upon 
parasite culture, so direct extraction from biological materials is important for 
characterization. 
These findings have important implications regarding the diagnosis, the choice of the most 
appropriate therapy and the possibility of developing drug resistance. The presence of L. donovani 
in all the five cutaneous samples examined suggests caution in the follow up of CL patients who 
could later develop VL symptoms.   
Many aspects of leishmaniasis in Sudan still need to be explored. However, these findings 
have also set the stage for future studies such as the prevalence of different species and vectors and 
the competence of Phlebotomus spp. in transmitting different Leishmania. 
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